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The primary aims of this project were completed largely in line with what was 
planned. However, because of disruption due to the Covid-19 pandemic, certain 
aspects were affected. Problems with remote access IT required for analysing a large 
dataset meant work was delayed by 4-6 weeks. This limited any capacity to complete 
additional analyses that might otherwise have been considered. There was also less 
opportunity to engage with the wider UK Biobank research group, limiting the scope 
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Chapter 1: Systematic Review  
 
Constructing a graphical model of the relationship between 
physical activity and cognitive function based on a systematic 
review of prospective evidence  
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Systematic review abstract 
Elucidating the factors that contribute to healthy ageing is an important research goal. 
Physical activity (PA) has been associated with benefits for cognitive function (CF). 
However, most of this evidence comes from longitudinal cohort studies which, in the 
absence of experimental design, have limited scope to make causal inferences 
regarding observed relationships. This review aimed to utilise recent methodological 
developments allowing researchers to formulate and answer stronger causal 
questions using observational data, by following a best-practice method for 
synthesizing evidence to produce a graphical causal model known as a directed acyclic 
graph (DAG). Following a search of 3 databases (EMBASE, MEDLINE and PsycINFO), 21 
observational studies on the PA-CF relationship were reviewed and their 
methodological quality, characteristics, and key findings were summarised. The 
outcomes of interest were the covariates and modelling practices employed in each 
study. The reported covariates were synthesised against a set of criteria to determine 
their role in the DAG as confounders or mediators of the PA-CF relationship. Every 
included study had some areas of methodological weakness. The resulting DAG 
included a wide range of biopsychosocial covariates spanning the entire life-course 
and indicated potential intermediate pathways between PA and CF via structural brain 
health. Strengths, limitations and implications of this review for modelling decisions 
are discussed, prior to the model being taken forward to inform an empirical analysis 
using data from the UK Biobank cohort. 
Word count: 228  
SR Key words: Physical activity; cognitive function; directed acyclic graph; healthy 







The term cognitive function (CF) describes the set of mental abilities that enable the 
acquisition and use of knowledge and skills throughout life. Humans vary in these 
abilities and lower CF is associated with a range of negative health outcomes (Batty, 
Deary, & Gottfredson, 2007). Reduction in certain aspects of CF occurs as part of 
normal aging (Harada, Love, & Triebel, 2013), but decline beyond the normal range is 
a feature of clinical presentations, from mild cognitive impairment (MCI) through to 
Alzheimer’s disease and other dementias (Gauthier et al., 2006; Husain & Schott, 
2016). Due to the aging population, the prevalence of conditions involving cognitive 
impairment is expected to rise and place increasing burden on society (Nichols et al., 
2019). Elucidating the factors associated with CF is thus an important task for 
researchers.  
Physical activity (PA) is defined as “... any bodily movement produced by skeletal 
muscles that requires energy expenditure” (Casperson et. al., 1985, p.126) and thus, as 
a concept, includes everyday activities such as DIY, walking and shopping as well as 
purposeful exercise and sport. PA has emerged as a modifiable risk factor associated 
with CF and neurodegenerative conditions (Blondell, Hammersley-Mather, & 
Veerman, 2014; Sofi et al., 2011). There are several pathways by which PA may affect 
CF. At the cellular level PA appears to facilitate neurogenesis, synaptogenesis and 
angiogenesis (Lista & Sorrentino, 2010) which may produce structural changes in grey 
matter volume (Erickson et al., 2019) and white matter integrity (Sexton et al., 2016). 
Other intermediate pathways between PA and CF may include behavioural and 
psychological mediators such as sleep and mood (Stillman, Cohen, Lehman, & 
Erickson, 2016). 
The gold standard of evidence in health science research is an experimental design 
such as the randomised controlled trial (RCT), and there is evidence from such trials 
demonstrating effects of targeted exercise on CF (Northey, Cherbuin, Pumpa, Smee, & 
Rattray, 2018). However, the broader conceptualisation of PA is less feasible to study 
experimentally and so most of the evidence comes from longitudinal cohort studies 
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which track people’s levels of PA ‘in the wild’ and estimate associations with various 
outcomes. Due to the observational design of such studies, researchers utilising these 
paradigms have traditionally been cautious about making causal claims from their 
findings (Rohrer, 2018). This is a position which is prudent, yet at odds with the aim of 
research to explain phenomena. Furthermore, such designs commonly utilise 
statistical adjustment strategies to improve their estimates without careful 
consideration of the assumptions behind, and implications of, these decisions, and 
thus may unwittingly introduce more bias into their models (Hernán, 2018). Examples 
of adjustment errors include failing to adjust for a confounder, over-adjustment for a 
mediator and inappropriate adjustment for a collider. In response to these limitations, 
researchers seeking to formulate and answer stronger causal questions using 
observational data have laid out an approach utilising a graphical tool known as a 
directed acyclic graph (DAG) (Pearl, Glymour, & Jewell, 2016). Constructing a DAG 
requires researchers to explicitly state the effect they are interested in (the 
‘estimand’), and then lay out their assumptions regarding relationships between the 
exposure, the outcome, and the relevant covariates. Through application of an 
algorithm to the specified model, a DAG can identify the necessary adjustment 
decisions required for causal interpretation of an estimand (see figure 1 for a more 
detailed description of DAGs in theory and practice). 
Of course, any DAG is only as good as the knowledge put into it by the researcher. 
However there has been a lack of guidance on how to produce DAGs in a robust way, 
until the recent publication of a methodological protocol on how to synthesise 
evidence to construct DAGs (Ferguson et al., 2020) and recommendations on how to 
present them (Tennant et al., 2019). Applying these methodological developments in 
the context of the PA-CF literature, can help identify key confounders and mediators 
and guide modelling decisions.  
Objectives  
This review aimed to utilise the recently developed method for constructing DAGs: 
Evidence Synthesis for Constructing Directed Acyclic Graphs (ESC-DAGs; Ferguson et 
al., 2020), applied to observational studies of the association between PA and CF. The 
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resulting DAG was then used to inform an empirical analysis of UK Biobank data, 
presented in Chapter two of this thesis. The purpose of this review was not to 
investigate the magnitude of associations between PA and CF; rather, it was to 
systematically investigate the factors that covary with PA and CF, in order to inform 
the construction of a causal DAG depicting the confounders and mediators of the 
relationship between PA and CF. Specifically, this review aimed to answer the 
following questions:  
(a) What clinical and sociodemographic factors, and health behaviours, do the 
included studies report as being associated with cognitive 
function/impairment/decline and/or physical activity?  
(b) How do the studies vary with regards to: the covariates included, how these are 
adjusted for, and the conclusions of the study? 
Figure (box) 1: DAGS – the basics  
Directed acyclic graphs (DAGs) represent a useful tool for researchers to lay out their theories and assumptions 
regarding the causal relationship between variables. A definition of causality that is compatible with DAGs has 
been posited as “A variable X is a cause of Y if Y in any way relies on X for its value” (Pearl et al., 2016). In practice 
this means DAGs are non-parametric in that they make no assumptions regarding the functional form of the 
relationships (e.g. linearity), the strength of relationships, or the causative direction (e.g. harmful or protective). 
The statistical software used in this thesis, DAGitty (Textor, Hardt, & Knüppel, 2011), applies an algorithm, known 
as the d-separation criterion (Pearl, 2009), which allows one to establish which variables need to be adjusted for, 
and which to leave unadjusted, given the researcher’s assumptions regarding the relationships between each 
pair of variables. The required variables are referred to as the minimally sufficient adjustment set. 
 
A DAG depicts conceptual variables as nodes, and putative causal effects between variables as arrows between 
nodes. The absence of an arrow between nodes encodes the strong assumption of no causal relationship for any 
member of the population. For a DAG to be complete and have a causal interpretation, all shared causes of all 
pairs of nodes must be depicted (these can be labelled as unknown factors if necessary). A sequence of nodes 
connected by arrows is a path, and paths must be acyclic (no path can feed back into itself). This acyclicity 
encodes the assumption that any variable, at a given point in time, cannot cause itself (although the same 
variable at different time-points, depicted as separate nodes, may cause one another). In terms of applying these 
principles to examples relevant to the present review, consider the simplest relationship depicted within a DAG, 
applied to the exposure and outcome of interest (figure 1.1). Note that DAGitty depicts the exposure variable as 
green and the outcome as blue with the symbol┃, and the presence of an unbiased path with a green arrow. 
Figure 1.1 encodes the following assumptions:  
 
1) The value of CF (i.e., whether it is low or high) depends in some way on the value of PA, for at least some        
members of the population. 
2) There are no other variables which have direct associations with both PA and CF (strong assumption of no 
shared causes).  
 




Naturally, such simplistic DAGs are unlikely to exist in relation to complex phenomena with multiple 
biopsychosocial causes. As more variables are integrated into a DAG, the assumptions made regarding the 
relationships between them determine the role each variable plays in transmitting the effect of interest. Three 
types of variable that should be considered in models are confounders (shared causes of the exposure and 
outcome which must be depicted in order for a DAG to have a causal interpretation), mediators (variables which 
transmit some of the effect of interest via an indirect pathway and are not mandatory to depict unless the 
researcher is interested in conducting mediation analyses), and colliders (a variable that is a shared outcome of 
exposure and outcome). Researchers may also be interested in moderators (also known as effect measure 
modifiers), which are variables that interact with each other to affect the outcome. Since DAGs are non-
parametric objects, moderators are simply depicted in the same way as confounders, but the researcher can 
model these statistically using interaction terms when they translate the DAG into a statistical model 
specification for their estimand of interest (e.g. regression equation). 
 
Simple examples of how confounders (figure 1.2), mediators (figure 1.3) and colliders (figure 1.4) would be 
depicted within a DAG are shown below.  
 
Figure 1.2: DAG depicting age as a confounder of the            Figure 1.3: DAG depicting brain health as a mediator 
PA-CF relationship.                                                                          of the PA-CF relationship.                                                 
 
In figure 1.2 the values of both PA and CF are assumed to rely in some way on the value of age. Age opens a 
biasing pathway between PA and CF, sometimes referred to as a backdoor path in the DAG literature. Age is 
therefore depicted as a confounder which must be adjusted for in order to ‘unbias’ any estimate of PA’s effect 
on CF. Note that the DAGitty software depicts confounders as pink nodes, and biased pathways as pink arrows. 
In figure 1.3 the value of brain health is assumed to rely in some way on PA, and the value of CF to rely in some 
way on brain health. Thus, as brain health is causally ‘down-stream’ of the exposure, it is represented as a 
mediator, and part of the total effect of interest. Mediators should thus not be adjusted for in estimating the 
effect total of PA on CF. Note that DAGitty represents mediators as blue nodes and unbiased paths between 
mediators and outcome as green arrows.  
 
Figure 1.4: DAG depicting an unknown variable mutually caused by PA and CF (a collider) 
 
In figure 1.4 a variable whose value is assumed to rely in some way on both PA and CF, is depicted as a collider. 
Importantly, a collider’s structural position blocks spurious association from flowing between exposure and 
outcome via this path and should thus not be adjusted for. When colliders are, often unintentionally, adjusted 
for, the backdoor path is opened, and can bias the exposure-outcome relationship, known as collider 
conditioning (Elwert & Winship, 2014). This can often be a problem in research when participation in the study, 
or missing data within the study, is related to exposure and outcome.  
 
Figure 1.5 illustrates a simple DAG with each type of variable represented. In this case DAGitty indicates that the 
minimally sufficient adjustment set required to estimate the total effect of PA on CF contains age and genetics 
(confounders), whilst brain health is part of the effect of interest (a mediator) and should be left unadjusted. 
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Figure 1.5: Simplified DAG depicting hypothetical confounders, mediators, and colliders. 
Method 
Protocol and registration  
A protocol for this review was written in accordance with the COSMOS-E guidance on 
conducting systematic reviews of observational studies of etiology (Dekkers et al., 
2019). This was registered on the Open Science Framework registry on 04/09/2020 
and is available from https://osf.io/wuycz/. This review has been written in 
accordance with COSMOS-E guidance so far as is possible, given the novel method of 
synthesis applied, and incorporates features of PRISMA guidance (Page et al., 2021) 
where appropriate.  
Eligibility Criteria  
• Condition being studied: Cognitive function as demonstrated by performance 
on objective cognitive tests. Where the outcome was measured categorically 
as impaired versus unimpaired, the threshold for impairment was as defined 
by study authors but would at a minimum require performance to be one 
standard deviation below the mean of a healthy comparison group. 
• Types of studies: Longitudinal cohort studies of prospective design were 
included. This design reflects the Biobank cohort resource which will be used 
for subsequent empirical analysis (Chapter Two).  
• Population: Community dwelling adults, free of cognitive impairment before 
the period of exposure to physical activity began and aged ≥45 to <80 at 
baseline. The upper limit of <80 serves to reduce the likelihood of undetected 
15 
 
pre-clinical cognitive decline at baseline, which would be expected to be higher 
in older samples. The lower limit serves to ensure that included samples are at 
least ‘middle aged’ at baseline, which reflects the Biobank cohort (Sudlow et 
al., 2015). Therefore, studies whose entire sample was <45 or ≥80, at baseline, 
were excluded. Where the sample’s range included ages both within and 
outside the ≥45 and <80 range, the study was only included if the mean age of 
the sample at baseline was between ≥45 and <80.    
• Exposure: Level of physical activity, measured using either self-report 
questionnaires  such as the International Physical Activity Questionnaire (Craig 
et al., 2003) or objective measures such as actigraphy. Where the exposure 
was measured categorically as active versus inactive the threshold for inactivity 
was as defined by study authors (e.g. not meeting World Health Organisation 
guidance for weekly PA). 
• Comparator: Given that the exposure (risk factor) is low physical activity, the 
unexposed group is those who engaged in greater levels, as defined by the 
study authors. 
• Outcomes: Given the nature of the present review questions, the outcomes 
were the covariates included in each study (clinical and sociodemographic 
factors, and health behaviours), and how these were treated in the analysis 
(e.g. as confounders, mediators or moderators). 
Search procedures  
The following databases were searched on 28/07/2020: Medline on the Ovid platform; 
Embase on the Ovid platform and PsycINFO on the EBSCOhost (EBSCO) platform. The 
search was restricted to English language publications between 01/01/2005 and the 
date of search. This date range was deemed appropriate as visual inspection of a 
histogram plotting the frequency of relevant articles by year indicated that a large 
majority of results were from after 2005. The sensitivity of the search strategy was 
tested by checking whether key papers known to be relevant were captured, and 
search terms were modified accordingly. Additional articles were identified by hand-
searching reference lists of relevant papers. See appendix 1.2 (p.97) for the full search 
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strategy including search terms and appendix 1.3 (p.98) for the test of search 
sensitivity. 
Search results were exported to EndNote X9 and titles and abstracts were screened by 
the lead author, using an eligibility checklist developed for this review (appendix 1.4). 
Articles which did not meet eligibility criteria were discarded. A second researcher 
(JW) screened a subset (n=100) of titles and abstracts. Inter-rater agreement was 84% 
(k =.56) indicating substantial consistency. Disagreements were resolved by discussion. 
Full texts for remaining articles were retrieved and screened by the lead author. A 
subset (n = 20) was screened by JW with agreement at 70% (k=.29), indicating fair 
consistency. As several disagreements occurred for the same reason these were 
discussed with a senior author (BC) and an amendment to the checklist was made 
providing clearer instructions (appendix 1.4, p.99). A further subset of 5 was screened 
by JW with 100% agreement.   
Data extraction 
The final set of eligible papers was ranked according to the number of covariates 
included. This method was chosen for efficiency, as it allowed the complete array of 
covariates amongst eligible articles to be captured by the minimum set of studies. 
Therefore, of the 60 eligible articles, 21 were taken forward for synthesis. Ranking 
articles according to their quality rating was also considered but deemed impractical. 
Data extraction from the articles included in the synthesis included the following 
variables: definition and measurement of PA and CF, covariates included in adjusted 
models and modelling practices employed (see appendix 1.5, p.102 for the data 
extraction form). Data extraction was carried out by the lead researcher, with a 
second researcher (JW) checking a subset of these (n=10) for accuracy and 
completeness. 
Risk of bias/quality rating  
COSMOS-E guidance (Dekkers et al., 2019) recommends that confounding bias, 
selection bias and information bias are assessed when evaluating observational 
studies of etiology. To ensure these were appropriately assessed, each included study 
was evaluated by the first author for methodological quality and bias using a critical 
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appraisal tool for prospective studies – The Joanna Briggs Institute (JBI) Checklist for 
Cohort Studies (Moola et al., 2017). In addition to this tool, item A2 from the Critical 
Appraisal Skills Programme (CASP) Cohort Study Checklist (2018) was included, to 
ensure that selection bias was directly assessed. In line with COSMOS-E guidance, no 
overall risk of bias score was assigned to each study; rather, the ratings for each item 
are presented transparently so that areas of strength or concern can be observed 
within and between studies (appendix 1.6, p.103). A second researcher (JW) 
independently rated a random sample (n=5) of the papers for comparison (90% inter-
rater agreement). Rating discrepancies were resolved by consensus.  
Synthesis strategy  
In the context of the present review questions, the aim of data synthesis was to 
elucidate and represent the causal structure of the relationships between PA, CF and 
covariates. Tables and narrative summaries were used to describe the range of 
covariates and modelling practices within the included articles. These were then 
synthesised to produce a causal diagram using the ESC-DAG method (Ferguson et al., 
2020), involving translating the conclusions of each included study into an individual 
DAG (see figure 2 for an illustration). All implied relationships were extracted into a 
combined index, and then all possible pairwise relationships between variables were 
assessed against a set of causal criteria. The resulting fully integrated DAG was then 
subjected to expert opinion (KF and BC), with any further variables not captured by 
the included literature integrated to the model by consensus. 
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Figure (box)  2: A demonstration of ESC-DAGs 
The ESC-DAGs process is described in detail by Ferguson et al. (2020). The method is applied below to a 
hypothetical study examining the effects of PA on CF with a small number of covariates (APOE-e4 genotype, age, 
brain health measured by MRI and smoking status). 
 
Stage 1: Mapping 
Purpose: To apply graph theory to the conclusions of each study. This creates an ‘implied graph’ (IG) which acts 
as a transparent structural template for translation into a DAG.  
1. Outcome variable of interest is set as DAG outcome(s).  
2. Exposure variable(s) of interest is set as DAG exposure(s).  
3. An arrow is drawn originating from the exposure(s), terminating at the outcome(s).  
4. All control variables are entered as unassigned variables.  
 
Figure 2.1: ESC-DAGs mapping stage, steps 1-4  
(Box 2 continued)  
5. An arrow is drawn originating from each control variable to the exposure(s) and outcome(s). 
 
 
Figure 2.2: ESC-DAGs mapping step 5 
 
6. Mediators, instrumental variables etc. are mapped as per the study’s conclusions and noted.  
7. The IG is saturated by drawing arrows between all confounders (direction does not matter until the 
translation stage) and all arrows are extracted to the main index. The recombination process (below) can be 
performed at this stage to help simplify an overly complex IG).  
 
Figure 2.3: ESC-DAGs mapping steps 6 & 7  
 
Stage 2: Translation 
Purpose: To apply causal theory to each relationship in the IG. This creates the DAG for the study. Each 
relationship (arrow) in the IG is assessed under sequential causal criteria and a counterfactual thought 
experiment.  
The posited arrow and its reverse are both assessed. Arrows may be retained as posited, reversed, or as bi-
directional. Otherwise, they are deleted. All retained arrows are entered into an index of relationships (figure 





(Box 2 continued)  
1. Temporality—can the posited cause precede effect? (If ‘yes’, proceed to next criterion. If not, assess reverse 
relationship.)  
2. Face-validity—is the posited relationship plausible? (If ‘yes’, proceed to next criterion. If not, assess reverse 
relationship.)  
3. Recourse to theory—is the posited relationship supported by theory? (Always proceed to the counterfactual 




Figure 2.4: ESC-DAGs translation steps 1-3  
4. Counterfactual thought experiment—is the posited relationship supported by a systematic thought 
experiment to explicitly draw out the implications of the posited assumption (once completed, always assess the 
reverse relationship unless already assessed).  
 
 
Figure 2.5: ESC-DAGs translation step 4.  





















(Box 2 continued)  
 
Figure 2.6: ESC-DAGs translation step 5.  
This process is repeated for all relevant studies that the researcher aims to integrate into the final conceptual 
model.  
 
Stage 3: Integration 1 (synthesis) 
Purpose: To combine the translated DAGs into one by synthesising all indexed relationships. 
1. A new DAG is created to serve as the integrated DAG (I-DAG).  
2. The focal relationship is added to the I-DAG (as per mapping steps 1–3).  
3. Each indexed arrow pertaining to the focal relationship (including its corresponding node) is added to the 
diagram.  
4. Each indexed arrow pertaining to other nodes is added (e.g. between confounders).  
5. Conceptually similar nodes should be grouped together in virtual space to aid the recombination process. 
 
Stage 4: Integration 2 (recombination)  
Purpose: To combine nodes for either practical reasons (i.e., to reduce complexity) or substantive reasons (i.e., 
to establish consistency). 
1. Is there theoretical support for combining two variables/nodes? 
2. Do the conceptually related nodes have similar inputs and outputs (i.e., do they ‘send to’ and ‘receive from’ 
the same nodes)? 
Results  
Study selection  
The study identification process is illustrated in Figure 3. The database search yielded 
5,898 results, and one additional paper was identified by hand-searching. The test of 
search sensitivity indicated that all 10 relevant papers were captured. A total of 60 
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studies were eligible. Given that the aim of this review was to identify and synthesise 
the range of covariates identified in primary studies, papers were synthesised in 
descending order by total number of covariates until the point that including further 
studies would only duplicate existing variables. To implement this process the first 
author counted and ranked the number of covariates from all 60 studies. This resulted 
in a total count of 73 covariates that were captured by 21 papers, which were taken 
forward for synthesis. After recombining different measures of similar constructs, the 
total number of conceptual variables was reduced to 56 (e.g., rather than representing 
BMI and waist circumference as separate nodes these were recombined into a single 
conceptual variable ‘adiposity’). Table 1 describes the key characteristics of the studies 
including age and size of samples, how PA and CF were defined and measured, and the 
key findings. Table 2 reports the covariates and modelling practices within each study.  
Risk of bias/quality results  
Full risk of bias/quality ratings are displayed in appendix 1.6. All of the included studies 
suffered from methodological limitations in at least one area. Most commonly this 
pertained to the recruitment of non-representative samples, introducing the 
possibility of selection bias, incomplete follow-up which compromises the internal 
validity of findings, and quality of the measurement of exposure, with many studies 
using unvalidated self-report measures to capture PA. For all but two studies there 
were concerns regarding differences between the exposed and unexposed groups on 
relevant covariate measures, which indicates high risk confounding bias. However, this 
was addressed by all studies through identification of confounders, and by 
implementing strategies to adjust for them (all studies). Another area of strength was 
in the outcome measures used, with all but one reporting assessments of CF using 
valid and reliable measures.  
Exposure measures and classification 
Most studies used self-report questionnaires to measure PA (only three used 
accelerometery). Studies most commonly divided the sample (e.g., into quartiles or 
tertiles) according the distribution of PA within the sample, though six studies entered 
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PA as a continuous variable. Only two studies used objective criteria (WHO guidance) 





Figure 3: PRISMA flow diagram 





Records removed before screening: 
Duplicate records removed (n = 0)* 








Reports sought for retrieval (n=303) 
Reports assessed for eligibility 
(n=303) 
Studies eligible for review (n=60) 
Records excluded  
(n = 244)  
Not longitudinal design  
No use of objective CF measures  
PA included as one of many exposures   
Conference abstracts/reviews articles 
Records identified from: 
hand searching (n=1) 
Reports sought for 
retrieval (n=1) 
Reports assessed for 
eligibility (n=1) 
Total studies included in review 
(n=21) 
Reports not retrieved (n=0) 
Identification of new studies via databases Identification of new studies via other methods 
Reports excluded: (n=0) 
Studies excluded after ranking by 
number of covariates (n= 39) 
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Outcome measures and classification  
The most common measures of CF were cognitive screening tools such as the Mini 
Mental State Examination (MMSE) which capture global CF. In some cases, batteries of 
standardised tests such as the Symbol Digit Modalities Test (SDMT) and the Stroop 
test, or bespoke (unstandardised) mental tasks, were used to measure separate 
cognitive domains. Other outcome measures included dementia diagnosis where 
reference was made to cognitive testing and impairment thresholds, but specific 
measures were not reported. Studies varied between modelling CF as a continuous 
variable, or as categorical, (i.e., impaired vs unimpaired). Where CF was treated as 
continuous, methods included using the raw scores from individual tests, or total 
scores from a screening tool. This was achieved in some cases by converting raw 
scores to z-scores centred around the sample mean and taking the mean of the z-
scores to indicate overall performance. Studies that used categorical definitions of 
impairment used existing criteria such as scores below a threshold on a screening 
measure (e.g., scores of <80 on 3MS), deviations from the sample mean of certain 
magnitude (e.g., z-scores at least 1.5 away from the mean), or reductions in CF of 
certain magnitude between baseline and follow-up (e.g., decline of >3 points on the 
Blessed Test).  
Key findings  
Of the 21 included studies, 18 reported some form of significant protective association 
between PA and CF, and three reported no significant association. Of these three, two 
were distinctive in terms of having younger baseline samples and longer follow-up 
periods than other studies (Morgan et al., 2012; Sabia et al., 2017). Furthermore, one 
study (which reported an overall protective association between PA and CF) found no 
association in a sub-analysis of participants who were retained longer than 10 years 
(Tan et al., 2017). One explanation explored by the authors to account for these 
anomalous findings, was that studies with older baseline samples may be at risk of 
reverse causation, whereby participants may already have preclinical cognitive 




Adjustment strategies  
The most common modelling technique was multiple regression, with confounders 
identified by statistically significant associations with the exposure and/or outcome. 
No study employed causal inference methods such as use of a DAG to guide modelling 
decisions. It was typical for authors to speculate about mediating mechanisms, based 
on significant regression coefficients, without formally testing these hypotheses 
through mediation analysis. In some instances, PA was treated as a moderator of 
another risk factor for CF (e.g., genetic risk, or sodium intake). Reduction of 
cardiovascular risk was often discussed as an intermediate pathway by which PA 
affects CF.  
Covariates reported by included studies   
Genetic  
The most common genetic covariate was APOEε4, which was included in adjusted 
models by six studies.  Being a carrier of the ε4 allele, as opposed to the ε3  and ε2 
alleles, is associated with higher risk of Alzheimer’s disease and cognitive decline (Liu, 
Kanekiyo, Xu, & Bu, 2013). The only other genetic variables were both included in the 
same study. These were variants of Insulin Degrading Enzyme and Brain Derived 
Neurotrophic Factor genes, which have both been associated with brain health and 
CF.  
Sociodemographic  
The most common sociodemographic variables included were age (all studies) and 
education (sixteen studies). Other commonly included variables were socio-economic 
status, ethnicity and marital status. One study included acculturation and one included 
measures of social support. 
Health behaviours  
The most common health behaviours included related to alcohol intake (ten studies) 
and smoking status (nine studies). Other variables were related to diet, including 
sodium intake and use of vitamins.    
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Table 1: Characteristics of the included studies  






Exposure measure Exposure 
classification 
Outcome measure Impairment 
classification 
Key findings  
(Barha et 
al., 2020) 
USA M= 73.6  2,873 10 years  Self-reported total 
minutes walking per 
week   
Participation in 
walking at least 10 
X in last year  




on 3MS  
Positive association between 
PA and global CF in both 
sexes.  
Positive associations 
between PA and EF and PS 
in females only.  
Positive association between 
PA and left dlPFC in females 
only.  
Negative association 
between PA and left 
hippocampal volume in 
females; positive in males.  
(Etgen et 
al., 2010) 






on frequency of 
strenuous activities  
No activity  
Moderate activity: 
< 3 times/week  
High activity: ≥ 3 
 times/week  
Global cognition: 6-
CIT  
Scores > 7  Negative association 
between PA at baseline and 
incident cognitive 
impairment at follow-up.  
(Fiocco et 
al., 2012) 
Canada M = 74.2  1,793 3 years  Self-report: Physical  
Activity for Elderly Scale 
(PASE) 
 
High or low 
activity based on 







between sodium intake and 





UK  M = 79  550 11 years  Retrospective PA: 
bespoke self-report 
measure rating general 
PA on 6 point to scale at 




(recorded at 79, 83, 87 
and 90): bespoke self-
report measure rating 
frequency of various 
leisure activities 
including PA  





residuals used to 
define an activity 
score for leisure 
activity and PA for 
each age category 
 
Contemporaneous 








used to extract a 
general latent 
cognitive ability (g) 
factor, which was 
used as the 
dependent variable  
Cognitive 
change, 




between PA and cognitive 
decline.   
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Exposure measure Exposure 
classification 
Outcome measure Impairment 
classification 

















174 M= 5.2 
years  
Self-report: lifestyle PA 
frequency and intensity, 
measured using the 
Community Healthy 
Activities Model Program 
for Seniors 
Questionnaire. 
Responses were assigned 
MET values to calculate 
total amount of 




data used to calculate 
mean daily minutes of 
light, moderate-vigorous 
and total PA.  
For self-report and 
objective 
measures PA was 
quantified in terms 
of amount of light, 
moderate -
vigorous and total 
PA, per week (self-
report) or per day 
(objective)  
Battery of cognitive 




were expressed as Z 
scores and these 
were used to create 
composite scores 
for global CF and 
each subdomain.  
Cognitive 
decline was 
defined as a 
drop of CF 
of >0.5 SDs 
from the 
mean rate of 
decline 
Negative association 
between self-reported light 
PA and risk of episodic 





vigorous PA and risk of 





UK  M= 65 10,652 10 years   Self-reported 
participation in mild, 
moderate and vigorous 
PA activities using a four 
point scale.  
Categorised into 
four groups:  
inactive (no PA on 
weekly basis), only 
mild at least once 
per week, at least 
moderate but no 
vigorous once per 
week and any 
vigorous activity at 
least once per 
week.  
Memory: a ten-
word recall test.  
 
EF: a category 













Positive association between 
PA at baseline and 
preservation of memory and 
EF over 10 years in females, 
and in EF only for males 
(Iso-Markku 
et al., 2016) 
Finland  M = 49.1 3,050  Self-report questionnaire 
regarding volume and 
intensity of leisure-time 
PA and commute-based 
PA, used to calculate 
total PA expressed in 
MET, then divided into 





were combined to 
reflect groups 
change in PA over 
time (being in the 
Global cognition: 
TICS   
Total score 
used as a 
continuous 
measure of 
global CF  
Negative association 
between level of PA and risk 
of cognitive impairment.  
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Exposure measure Exposure 
classification 
Outcome measure Impairment 
classification 
Key findings  
lowest quintile 
both years = 
‘persistently 
inactive’; moving 
out of lowest 
quintile = ‘changed 
activity’; highest 





USA  M = 73.2 1,740  M = 6.2 
years  
Self-report questionnaire 
regarding frequency of 
participation in a range 
of exercise for at least 15 
minutes. Frequency of 
exercise was calculated 
as total number of such 
episodes per week.  
Being active was 
defined as 
exercising at least 
three times per 
week.  
Global cognition: 
CASI at baseline, 







incident dementia.  
A CASI score 





between exercising 3 or 
more times per week and 
incident dementias.  
(Morgan et 
al., 2012)  
UK  56  2,959 16 years   Self-report 
questionnaires regarding 
duration and frequency 
of work-related and 
leisure-time PA.  
 
Both work-related 
PA and leisure 
time PA were 
divided into 
tertiles to define 
low, moderate and 
high activity 
groups.  





positive screens.  
A CAMCOG 





No significant association 






USA  75.1 1,345   Current leisure time PA: 
self-report questionnaire 
regarding frequency and 
duration of activities of 
activities of various 
intensity (according to 
MET weights). Total time 
was used to calculate 
MET hours/week.  
 
Current leisure 
time PA was 
categorised as 
low, moderate or 
high according to 
MET hours.  
 
Past leisure time 






battery (tests not 
reported).  
At least 1.5 
SDs below 




diagnosis   
Negative association 
between both current and 










Exposure measure Exposure 
classification 
Outcome measure Impairment 
classification 
Key findings  
Past leisure time PA was 
measured retrospectively 
using similar questions to 
estimate MET minutes 
for life periods 12-25, 26-
50 and  > 50 years old.  
low, moderate and 




et al., 2016) 
Sweden  71.8 555 6 years  Self-report questionnaire 
regarding duration and 
frequency of 
participation in activities 
categorised by intensity.  
Three categories 
of PA created 
based on WHO 
guidance: 
inadequate (less 
than 3 episodes of 
light and/or 
moderate-
vigorous PA per 
month); health-
enhancing (light 
exercise at least 





times per week).  
MMSE   MMSE 
change score 
over 6 years  
PA had a protective 
interactive effect on 
negative association 
between inflammation 
markers, brain health and 
CF.  
(Podewils 
et al., 2005) 
USA  74.8  3,375 M = 5.2 
years  
Self-report questionnaire 
regarding frequency and 
duration of activities 
assigned MET weightings 
and used to estimate PA-
related energy 
expenditure per week.  
 
An index of number of 
activities participated in 
ranging from 0-14 was 
also used as a continuous 
measure of PA 
frequency.    
Energy 
expenditure and 
PA frequency used 
as continuous 





(3MS), or TICS (if 




below 80 or 




TICS score of 
below 28  
Negative association 
between PA frequency and 
risk of all dementias   
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Exposure measure Exposure 
classification 
Outcome measure Impairment 
classification 
Key findings  
(Rabin et 
al., 2019)  
USA 73.4 182 Median 
= 6 years  
Objective: pedometer 
used to calculate mean 
steps per day 
Number of steps 












Higher levels of PA 
attenuated the associations 
between AB burden and 














minutes in each 
activity, then split 
into quartiles: 0, 
0.01-1.24, 1.25-


















between PA and rate of 
cognitive decline amongst 
racially white sample, but no 

























frequency and duration 
of PA, in teens, 30s and 
concurrently at each 
assessment wave 
Classified as active 
if engaging in any 





EF (Trails B; verbal 







points to allow for 







Positive association between 
concurrent PA and better 
CF, which was age 
dependent (stronger effect 
at older ages).  
PA in early adulthood also 








1,449 M = 20.7 
(active) 
 








active if engaging 
in any level of PA ≥ 
2 times/week and 
Global cognition 
(MMSE) and full 
clinical dementia 
assessment for 
positive screens.  
Score of <25 
on MMSE 
Negative association 
between mid-life PA and risk 
of dementia  
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Exposure measure Exposure 
classification 
Outcome measure Impairment 
classification 





























10,308 M =26.6   Self-report:  
questionnaire regarding 
frequency and duration 
of PA, assigned MET 
weightings and used to 
estimate PA-related 
energy expenditure per 
week. 
Classified as active 
if meeting WHO 
criteria of ≥ 2.5 
hours of moderate 
to vigorous 
PA/week, an 





recall test  
 
EF: Alice Heim 4-I 




Fluency: letter and 
category fluency  
 
Global cognition:  










CF   
No association between PA 
and cognitive decline, or risk 
of dementia.  
 
However, PA levels decline 
in dementia cases 9 years 
prior to diagnosis, 
suggesting reverse 
causation.  
(Tan et al., 
2017) 












frequency and duration 
of PA, assigned MET 
weightings to create a PA 
index. Scores on this 
index were divided into 
sex specific quintiles.  
PA index quintile 
entered as ordinal 
exposure.  
Battery of cognitive 
tests and dementia 
clinical assessment.  
 
Incident dementia 









between PA and risk of 
dementia. No association in 
sub-analysis of longer-term 
follow-up (>10 years).  
 
Positive associations 
between PA and total brain 












participation in everyday 
PA over a 2-year period. 
Total scores reflect 
Total PA frequency 
score entered as 
continuous 
measure.  
EF (Hayling and 
Brixton tests, 
Stroop test and 
Colour Trails test).  
Latent factor 
of EF scores 
extracted 




Positive association between 
PA and EF.  
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Exposure measure Exposure 
classification 
Outcome measure Impairment 
classification 
Key findings  























M = 4.1 
years 
Self-report:  Self-report: 
questionnaire regarding 
frequency of 
participation in PA. 
Scores summed to create 
PA index.  





Battery of cognitive 
tests including 
Global cognition 





















No association between PA 




USA 70.6 1,228  5 years   Self-report:  
questionnaire regarding 
frequency and duration 
of PA, assigned MET 
weightings. Moderate-
heavy PA was activities ≥ 
6 MET, light was 
activities <6 MET. For 
analytical purposes no 
activity and light activity 
were combined as the 




activity and light 
activity were 
combined and 













and Boston Naming 
Test) to create 
domain scores for:  
EF, PS, Episodic and 





defined as a 
Z score of 




between PA and cognitive 
decline.   
Notes for table 
a Follow up time refers to mean (M) or median if reported by authors. Otherwise the figure pertains to the upper range of the follow-up period. 
Abbreviations:  3MS, Modified Mini Mental State Exam; 6-CIT, Six-item Cognitive Impairment Test; BSR, Buschke-Fuld Selective Remining test; CAMCOG, Cambridge Cognition Examination; 
CASI, Cognitive Ability Screening Instrument; CF, Cognitive function; DSST, Digit Symbol Substitution Test; EBT, East Boston Story test; EF, Executive function; M, Mean; MCI, Mild Cognitive 
Impairment; MET, Metabolic equivalent of task; MMSE, Mini Mental State Exam; PA, Physical activity; PACC, Preclinical Alzheimer Cognitive Composite; PS, Processing speed; SDMT, Symbol 




Table 2: Covariates and modelling practices of the included studies   
Study  Covariates included   Modelling and 
adjustment 
strategies   
(Barha et al., 
2020) 
Age, BMI, Cerebrovascular disease, Cardiovascular 
disease, Depression, Diabetes, Education  
Latent growth curve 
modelling  
(Etgen et al., 
2010) 
Age, Alcohol, BMI, Baseline CF, Depression, Diabetes, 
Heart disease, Hypertension, Hyperlipidemia, Kidney 
Disease, Nursing home status, Smoking, Triglycerides 
Multiple regression  
(Fiocco et al., 
2012) 
Age, BMI, Calcium, Cholesterol, Diabetes, Diastolic 
BP, Diet quality, Education, Energy intake (calories), 
Heart disease, Hypertension, Smoking, Sodium, 
Systolic BP 
Multiple regression  
(Gow et al., 
2017) 
Age -11 IQ, Alcohol, Education, SES, Sex, Smoking 
 




Acculturation, Age, Chronic health problems, 
Depression  
Multiple regression   
(Hamer et al., 
2018) 
Age, Alcohol, BMI, Chronic lung disease, Diabetes, 
Depression, Education, Hypertension, Income, Sex, 




Age, BMI, Binge-drinking, Education, Hypertension, 
Living alone, Smoking, Time (follow-up)  
Multiple regression  
(Larson et al., 
2006) 
APOEε4 status, Age, Alcohol, Cerebrovascular 
disease, Depression, Diabetes, Education, Fish oil, 
Heart disease, Hypertension, Physical performance, 
Self-rated health, Smoking, Vitamin use 
Multiple regression  
(Morgan et al., 
2012)  
Age, Anxiety (state & trait), Alcohol, BMI, 
Cardiovascular disease, Marital status, Mental 
disorder, Premorbid CF, Smoking  
Multiple regression  
(Ogino et al., 
2019) 
APOEε4 status, Age, Alcohol, BMI, Depression, 
Education, Diabetes, Insulin medication, Heart 
disease, Head injury, Hypertension, Psychiatric 
disease, Smoking, Time (follow-up) 
Multiple regression  
(Papenberg et 
al., 2016) 
Age, Cardiovascular burden, Diabetes, Education, 
IADL, Inflammation, MRI (grey matter volume of PFC, 








ADL., IADL, APOEε4 status, Age, Baseline CF, 
Education, Ethnicity, MRI (white matter grade), Sex, 
Social network, Social support 
Multiple regression  
(Rabin et al., 
2019)  
APOEε4 status, Age, BMI, BP, Cardiovascular risk, 
Depression, Diabetes, Education, MRI (grey matter 
volume, PET (amyloid beta burden) 
Multiple regression: 
PA modelled as 
moderator of AB 
burden risk  
(Rajan et al., 
2015) 
ADL, Age, Cardiovascular risk, Cognitive activity, 
Incapacity, Physical function, Race, SES, Sex   
Multiple regression  
(Reas et al., 
2019) 
Age, Alcohol, BMI, Cardiovascular risk, Education, 
Sex, Smoking,  
Multiple regression  
(Rovio et al., 
2005) 
APOEε4 status, Age, Alcohol, BP, Cholesterol, 
Dementia, Diabetes, Education, Heart attack, 





Study  Covariates included   Modelling and 
adjustment 
strategies   
(Sabia et al., 
2017) 
Age, Alcohol, Antihypertensive medication, BP, 
Cardiovascular disease, Diabetes, Diet, Education, 
Ethnicity, Marital status, SES, Self-rated physical 
function, Smoking, Stroke 
Multiple regression  
(Tan et al., 
2017) 
APOEε4 status, Age, Cardiovascular disease, 
Diabetes, Education, MRI (hippocampal volume), 
Plasma homocysteine, Stroke  
Multiple regression  
(Thibeau et al., 
2016) 
Age, Education, Genetics (IDE & BDNF genes) 
 
Latent growth curve 
modelling and 
multiple regression  
(Verghese et 
al., 2009) 
Age, Baseline CF, Cognitive Activity, Education, 
Medical illnesses, Sex 
Multiple regression  
(Willey et al., 
2016) 
Age, Alcohol, BMI, Crystallised ability, Education, 
Hypertension, MRI (atrophy, infarct, white matter 
disease)  
Multiple regression  
Notes for table 
Abbreviations: APOE, Apolipoprotein E; BDNF, Brain-derived neurotrophic factor; BMI, Body Mass Index; BP, Blood pressure; 
CF, Cognitive function; IADL, Instrumental activities of daily living; IDE, Insulin degrading enzyme; IQ, Intelligence Quotient; 
MRI, Magnetic Resonance Imaging; PA, Physical activity; PET, Positron Emission Tomography; SES, Socio-economic status 
APOE, Apolipoprotein E  
 
Medical conditions  
The most common medical variables included related to cardiovascular and cerebrovascular 
risk, in line with theoretical mechanism of PA’s protective effect. Studies frequently used 
self-report or medical records to establish diagnoses of, for example, heart disease, 
hypertension and stroke. Biomarkers were also used to capture cardiovascular risk including 
blood-pressure, cholesterol and calcium. Cardiometabolic conditions such as diabetes and 
chronic kidney disease were also frequently accounted for. Other factors less frequently 
included were head injury, inflammation, locomotor disorders and musculoskeletal 
conditions.  
Mental health and psychiatric conditions   
Depression was included by seven studies. One study included anxiety, and one reported 
psychiatric disease as a covariate without specifying which conditions were included in this 
category.  
Brain health 
Five studies included MRI measures of brain health. These mainly related to the volume of 
grey matter, including at the whole-brain level and in regions of specific interest such as the 
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hippocampus, pre-frontal cortex, caudate and putamen. Two studies also included MRI 
measures of white-matter integrity, such as the volume of hyperintensities. Other MRI 
measures included number of silent infarcts identified. One study included a measure of β-
Amyloid burden, using Positron Emission Tomography imaging.  
Earlier life variables  
Several studies took account of the contribution of engagement in PA at age periods earlier 
than baseline (assessed using retrospective questionnaires), including during teenage years, 
at age 30 and in middle-age. One study included childhood IQ as a measure of early-life CF, 
and another specifically included a measure of crystallised abilities to represent CF across 
the lifespan.  
Other variables added to the model by consensus  
Based on existing knowledge of factors associated with CF, the following variables were 
identified in addition to those which emerged from the review process: family history of 
dementia, pollution (Power, Adar, Yanosky, & Weuve, 2016), maternal smoking (Corrêa et 
al., 2021), childhood trauma (Cassiers et al., 2018) and psychotropic medication (Cullen et 
al., 2015). A generic conceptual variable, ‘ancestry’, was also depicted within the model to 
represent various historical factors influencing ethnicity, genome and familial history. 
Additionally, as per the translation phase of the ESC-DAGs protocol, certain conceptually 
similar variables were recombined into single nodes. For example, BMI and waist 
circumference were combined into a single node ‘adiposity’ and energy intake, triglycerides, 
and vitamin use were combined into the node ‘diet’. Making recombination decisions at the 
conceptual DAG stage did not preclude entering each component of a recombined node 
separately at the analysis stage (if there were matches for these within the available 
Biobank data).   
Synthesis of findings to produce a conceptual model  
Synthesis was performed according to the ESC-DAGs method (demonstrated in figure 2. In 
short, this required mapping the conclusions of the 21 included studies in the form of 
individual DAGs, extracting the total range of covariates into an index, and assessing the 
relationships between all possible pairs of nodes against a set of causal criteria. The 
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decisions were then depicted in an integrated conceptual DAG, presented in figure 5, below. 
It is worth clarifying some of the assumptions that underpinned the decisions within the 
model.  A life-course perspective was taken to group variables together according to the 
life-period during which they are assumed to occur, such that temporality flows left to right 
within the diagram (Tennant et al., 2019). Each life-period was assigned a numeric prefix for 
pragmatic reasons in organising the decision index and resulting code for the model. These 
were as follows:   
- ‘00_’: Factors which occurred prior to birth (e.g., assignment of sex at conception).  
- ‘01_’: Factors which occurred in early life (e.g., education, traumatic events, and 
development of traits).  
- ‘02_’: Sociodemographic factors which are realised into adulthood (e.g., 
socioeconomic status, employment, and marital status). 
- ‘03_’: Early adult (approximately 18-40) health behaviours which are closely 
associated with sociodemographic factors (e.g., PA participation, alcohol 
consumption and smoking status).  
- ‘04_’: Adult health outcomes which are closely associated with earlier health 
behaviours (and earlier factors).  
- ‘05_’: Relevant medications which are naturally associated with health status (e.g., 
psychotropic and antihypertensive medication).  
- ‘06’_ & ‘07’: The exposure period, representing baseline (middle-aged) level of PA 
and CF as well as intermediates between these two nodes (brain health, anxiety, 
sleep and mood). 
The assumptions above are illustrated in DAG format in figure 4, below. The full conceptual 








Figure (box) 4: Temporal assumptions within the model  
Figure 4.1: DAG representing the life-course temporal assumptions of the model  
Factors grouped within each time point in time can affect those later in time either directly, or indirectly through intermediates:  the past affects the future, the future does not affect the 
past. Note, that the minimal adjustment set is also a function of what is ‘set’ as the effect of interest (according to the research question). Figure 4.2, below, encodes exactly the same 
assumptions regarding structure of causation, yet by ‘setting’ the exposure earlier in time, a larger proportion of the graph is downstream, and thus a part of the effect of interest.  
 
 




Pre-birth  Early life   Early adulthood  Adult health behaviours  Adult health outcomes        Baseline age   







Main findings  
The primary aims of this review were to elucidate the factors associated with PA and CF in 
longitudinal studies of middle-aged to older adults and synthesise these findings to produce 
a structural causal model, following a recently developed best-practice method to do so 
(Ferguson et al., 2020).  In the 21 included studies, factors associated with PA and CF 
included a broad range of biopsychosocial variables, that spanned the entire lifespan. 
Commonly included biological factors included genetic variants associated with CF, 
measures of brain health and cardiometabolic risk factors such as stroke, heart disease and 
diabetes. Psychological variables included mental health, particularly depression. 
Sociodemographic variables commonly included were age, education and ethnicity, whilst 
health behaviours such as alcohol consumption and smoking status were often included. 
Studies typically used multiple regression to adjust for these factors and estimate the 
association between PA and CF. No study employed a causal inference approach such as 
using DAGs to guide their adjustment strategies. Authors often suggested support for 
hypothetical mediators of the PA effect when regression coefficients were smaller after 
adjusting for potential mediators (e.g., cardiovascular risk factors). However, no study 
formally tested such hypotheses by performing mediation analysis. The majority of studies 
reported some form of protective association between PA and CF. Two of those which 
reported no association benefited from reduced risk of reverse causation due to their 
younger baseline samples and longer follow-up periods.   
Summarising the model  
Given the complexity of the conceptual model it is beyond the scope of this thesis to discuss 
all the decisions made during the synthesis process. However, key assumptions regarding 
the structure of the model are discussed below. The model leveraged the causal criterion of 
temporal validity to simplify potential bidirectionality between concepts and achieve 
acyclicity. However, it is acknowledged that there remain multiple instances of plausible 
bidirectional relationships within the model (e.g., the posited direction of marital status-
social network could plausibly be reversed). Having established assumptions regarding 
temporal order, it was further assumed that each variable affected those downstream of it 
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directly, unless its effect was entirely captured by an intermediate. For instance, the 
absence of direct arrows between acculturation (early life) and various adult health 
outcomes encodes the assumption that the effects of acculturation on health outcomes are 
entirely captured by sociodemographic and health behaviour intermediate variables.   
Overall, the model reflects existing literature on theoretical pathways between PA and CF 
such as via reduction of cardiovascular risk (Yaffe et al., 2014), improved brain health 
(Erickson et al., 2019) and psychological factors such as mental health and sleep (Stillman et 
al., 2016) and, also, the possibility that CF may be differentially sensitive to PA participation 
at different life-periods (Gow et al., 2017).  This latter point means that decisions regarding 
adjustment are necessarily a function of which life period is designated as the exposure of 
interest (as discussed in figure 4). For instance, according to the model, if one aims to 
estimate the effect of early adulthood PA on mid-life to early old-age CF, then the health 
outcomes are downstream of PA and thus are mediators. Whereas, to estimate the effect of 
PA occurring more proximally to baseline CF, these health outcomes become confounders 
(reflecting the assumption that these medical conditions reduce PA participation and harm 
CF). In this thesis the decision regarding which period of PA participation is designated as 
the exposure must be made in the context of the empirical data used in chapter two.  
Strengths, limitations, and recommendations 
The use of a causal inference approach to explore the effect of PA on CF represents a novel 
contribution to the literature. The construction of the DAG was conducted using a 
systematic and transparent method that addresses the lack of guidance which has been 
identified in existing literature (Tennant et al., 2019). However, a consequence of this level 
of rigour was a highly complex model which posed practical limitations in terms of detailed 
interrogation of different versions of the model (due to DAGitty software crashing). This 
meant that the implied adjustment sets that would follow from alternative assumptions 
regarding the direction of causation between pairs of variables that were plausibly bi-
directional (i.e., the arrow between them could have been reversed), were not fully 
interrogated. Based on this experience of applying the methodology, it is the opinion of the 
first author that the full ESC-DAGs protocol, whilst certainly robust, would not be feasible to 
use routinely. In particular, researchers considering using the method should be aware that 
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if the requirement to begin DAG construction from the assumption of full saturation is 
observed, then models above a certain number of nodes (approximately 30) become 
unfeasible to interrogate using the browser version of DAGitty. It would be helpful to 
consider if a ‘middle ground’ could be reached, i.e., a version of ESC-DAGs that balances the 
rigour of the protocol with pragmatism required for wider use. It should also be noted that,  
despite being subject to a set of rigorous and transparent criteria, the assessment and 
decisions of relationships between nodes are made by one researcher only. Therefore, in 
future applications of the method it may be of interest to conduct an inter-rater reliability 
check on some, or all, of the decisions made.  
There were further methodological limitations to this review. The way eligible studies were 
prioritised for synthesis according to how many covariates they contained represented a 
pragmatic way of capturing the range of relevant covariates with the fewest articles but 
meant that articles of potentially higher methodological quality were excluded. Finally, the 
screening process, ROB rating and data accuracy check was only completed for a percentage 
of the total articles, the search strategy did not utilise forward citation searching (meaning 
some eligible articles may have been missed) and numbers pertaining to each reason that 
studies were excluded at full stage were not recorded (a deviation from PRISMA guidance).   
Next steps  
In chapter two of this thesis the conceptual model is taken forward and used to inform an 
empirical analysis using UK Biobank data, which represents the integration phase of the ESC-
DAGs method.  
Conclusions  
This review captured a broad array of covariates that are relevant in modelling the effect of 
PA on CF, and transparently represented assumptions regarding the causal structure of 
these variables in a graphical model. Methodological limitations mean some relevant factors 
may not have been captured. The resulting model is taken forward to inform empirical 
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Plain English summary of Major research Project  
Title: Estimating the effect of physical activity on cognitive function within UK Biobank 
Background:  
Cognitive function (CF) describes the range of mental abilities like memory, language, 
problem solving and visual ability that make it possible for humans to learn and use 
knowledge and skills. When CF is reduced people can find it hard to participate in their 
daily activities and their quality of life may suffer. Because of this, researchers are 
interested in identifying ways of protecting CF. Existing studies have shown that 
people who do more physical activity (PA; e.g., exercise, housework, DIY) have better 
CF than those who are inactive, which might be because PA helps keep the brain 
healthy. However, there are lots of other factors that are related both to PA and CF, 
and the way that previous studies have been designed means the strength of the true 
relationship between PA and CF remains unclear.  
The present study used a type of diagram known as a directed acyclic graph (DAG) to 
help identify which of these other factors need to be adjusted for when analysing data 
on PA and CF. Data from a very large cohort study (UK Biobank) was then used to 
estimate the strength of the effect of PA on CF in middle-aged and older adults. 
Aims and questions:  
This study aimed to estimate how much PA affected CF for people in the UK Biobank 
sample, firstly using data collected at the beginning of the study, and then using 
follow-up data collected several years later.  
If it looked like there was a strong effect of PA on CF, then a secondary aim was to 
check how much of this was explained by structural differences in people’s brains.  
Methods 
People reported how much PA they did, and some of these people also had their level 
of PA measured directly using a device worn on their wrist. People completed 
different mental tasks known as cognitive tests, as a measure of their CF. Some people 
also had their brains scanned to measure how healthy their brains were. Statistical 
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models were then used to see how much PA affected CF, taking account of other 
aspects such as age and lifestyle.  
Main findings  
Surprisingly, there was very little relationship between PA and CF in our study. It might 
be that UK Biobank participants are healthier than other groups where this effect has 
been observed before, or that this sample is still too young for changes in CF related 
to PA to be detected reliably.  
Conclusions  
The findings of this study may have arisen because people in UK Biobank are not 
representative of the wider population. This would mean that caution is required 
when interpreting studies using this sample. It may also be the case that previous 
studies over-estimated how much PA can affect CF. One way to find out could involve 
repeating this study as the people in UK Biobank get older to see if the expected effect 
emerges later.  




Estimating the effect of physical activity on cognitive function within UK 
Biobank 
Abstract: 
Physical activity (PA) has been associated with benefits for cognitive function (CF), but 
previous estimates of the strength of this relationship may have been biased due to 
limitations in modelling practices that are common amongst observational studies. 
The present study aimed to address this by using a rigorously constructed conceptual 
causal model to guide an empirical analysis estimating the effect of PA on CF in the UK 
Biobank cohort of middle-aged and older adults. It was hypothesised that higher PA 
would be associated with better CF, and that this effect would be mediated by 
structural differences in brain health. PA was measured subjectively by self-report and 
objectively using accelerometry, and CF was measured using objective cognitive tests 
which have been validated against widely used standardized measures. Composite CF 
measures were derived to represent general and domain-specific performance. The 
wide range of data within UK Biobank allowed a close approximation of the covariate 
adjustment set specified by the model to be obtained, as well as MRI measures of 
brain health as potential mediators. Effect coefficients were estimated using 
regression models (cross-sectional: n = 31,854 to 305,294 unadjusted, n = 2,548 to 
29,810 adjusted; longitudinal: n = 21,225 to 30,330 unadjusted, n = 4,805 to 6,840 
adjusted). Results indicated very small effect sizes of inconsistent direction. As the 
hypothesized effect of PA on CF was not observed consistently, mediation analysis was 
not conducted. Reasons for the unexpected findings are discussed in the context of 
previous literature, and selection bias within UK Biobank.   
Word count: 250 
Key words: Physical activity; cognitive function; directed acyclic graph; healthy ageing; 






Conceptualisation and measurement of cognitive function  
The term cognitive function (CF) describes the set of mental abilities that enable the 
acquisition and use of knowledge and skills throughout life. The study of CF has a long 
history within psychology and is often described within the literature as intelligence or 
cognitive ability (Deary, 2001). Whichever term is favoured, it is recognised that the 
structure of CF is multidimensional and consists of abilities within subdomains such as 
memory, speed of processing, verbal ability and reasoning (Deary, 2020). The 
psychometric approach to cognitive testing involves measuring people’s performance 
on various tasks that tax abilities in a particular domain (although all tests draw on 
multiple domains to some degree). It has been consistently found that people’s 
performance on different tasks is positively correlated, and that the magnitude of this 
relationship is stronger for tests that primarily tax the same domain. This commonality 
across tests and domains has often been treated as a single latent factor – ‘g’, which 
accounts for around 50% of the variance in test performance (Fawns-Ritchie & Deary, 
2020). Prominent theoretical accounts of CF (Carroll, 1993), and widely used cognitive 
tests (Wechsler, 2008), reflect the hierarchical structure of CF in three-stratum models 
comprising a general factor, underpinned by broad subdomains and narrow individual 
test abilities. However, the level at which CF is conceptualised and measured varies 
according to the aims of the researchers and clinicians who use the construct. General 
population research is commonly concerned with the underlying general factor, 
whereas neuropsychologists working with clinical populations are often concerned 
with domain specific deficits (Vakil, 2012). Researchers in the field of cognitive aging 
often use screening measures to identify impairment at the global level and thus use 
total scores across domains (Folstein, Folstein, & McHugh, 1975), or create composite 
scores which take an average across domains (Halloway, Wilbur, Schoeny, & Barnes, 
2017), as described in chapter one of this thesis.  
Neuroanatomical correlates of CF  
Whether conceptualising CF at the global level or the domain level, it is clear that 
these abilities are neurologically instantiated. Brain imaging studies, typically using 
magnetic resonance imaging (MRI), show associations between various characteristics 
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of the brain and CF. In terms of size, both whole-brain volume and the volume of 
specific regions have shown positive associations with CF. Estimates for the 
correlation between whole-brain volume and CF from meta-analyses range from r = 
0.24 (Pietschnig, Penke, Wicherts, Zeiler, & Voracek, 2015) to r = 0.39 (Gignac & Bates, 
2017). The correlation between whole-brain volume and CF in the UK Biobank general 
population cohort has been estimated at r = 0.28 (Cox, Ritchie, Fawns-Ritchie, Tucker-
Drob, & Deary, 2019). Specific regions implicated in CF include the hippocampus, 
thalamus, caudate, putamen, pallidum and amygdala (Miller et.al., 2016). Measures of 
white matter integrity are also associated with CF, including tract integrity (Penke et 
al., 2012) and white matter damage identified by MRI hyperintensities (Puzo et al., 
2019; Ritchie, Bastin, et al., 2015). A study which combined different neuroimaging 
measures within multivariate models found that, overall, 18-21% of variance in CF was 
accounted for, with brain volume contributing 12%, cortical thickness 5% and white 
matter hyperintensities 2% (Ritchie, Booth, et al., 2015).  
Conceptualisation and measurement of physical activity  
It is important to clarify the distinction between physical activity (PA) and exercise.  PA 
is defined as “... any bodily movement produced by skeletal muscles that requires 
energy expenditure ”, whereas exercise is “physical activity that is planned, structured 
and repetitive”(Casperson et. al., 1985, p.126). PA is thus a broader category which 
contains everyday activities such as DIY or shopping, as well as exercise. Physical 
inactivity is a leading risk factor for worldwide mortality and is associated with health 
outcomes such as obesity, diabetes, cancer and heart disease (Lear et al., 2017). 
Researchers typically conceptualise PA along a continuum, and tools such as the 
International Physical Activity Questionnaire (IPAQ) categorise activities according to 
their intensity as ‘light’, ‘moderate’, and ‘vigorous’ (Norton, Norton, & Sadgrove, 
2010). The World Health Organisation (WHO) recommends that adults should 
undertake 150-300 minutes of moderate intensity, or 75-150 minutes of vigorous 





Physical activity and cognitive function  
There is a broad epidemiological literature examining the effects of PA on CF. A 2009 
review (Hamer & Chida, 2009) included sixteen studies measuring associations 
between PA and neurodegenerative disease in a meta-analysis and reported 
significantly reduced risk in highest vs lowest activity categories for dementia, 
Alzheimer’s disease (AD) and Parkinson’s disease. In a similar study cognitive decline 
(rather than neurodegenerative disease diagnosis) was used as the outcome and it 
was found that the people who performed a high level of PA were 38% less likely to 
experience cognitive decline than those categorised as sedentary, and even those who 
performed low-to-moderate PA were 35% less likely (Sofi et al., 2011). A meta-analysis 
for both cognitive decline and dementia found a significant protective effect of PA for 
both, though this was stronger for cognitive decline (Blondell, Hammersley-Mather, & 
Veerman, 2014). Another study analysed the effect of PA separately for cognitive 
decline, AD, vascular dementia and all-cause dementia and found significant 
protective effects of PA, in order of magnitude, for AD, all-cause dementia and 
cognitive decline, and a non-significant effect for vascular dementia (Guure, Ibrahim, 
Adam, & Said, 2017). Most recently an umbrella review examined 24 systematic 
reviews and meta-analyses of longitudinal evidence of PA’s effect on health outcomes 
including cognitive decline (6 studies), dementia (5 studies) and AD (5 studies) 
amongst older adults (Cunningham, O'Sullivan, Caserotti, & Tully, 2020). The authors 
concluded that there is convergent evidence of reduced risk of these outcomes 
associated with meeting the WHO guidance for PA. Chapter one of this thesis 
reviewed longitudinal studies of PA and CF, and found that 18 out of the 21 included 
papers reported some form of protective association.  
Potential mechanisms  
There are several pathways by which the benefit of PA on CF may operate. As already 
outlined, variance in CF is associated with neuroanatomical differences. One review 
synthesised findings of structural brain changes associated with PA and concluded that 
there is evidence of modification by PA in up to 80% of grey matter (Batouli & Saba, 
2017). Specific regions which appear to be implicated are the hippocampus, prefrontal 
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cortex and caudate nucleus (Erickson, Hillman, & Kramer, 2015). A review focusing 
specifically on hippocampal changes found PA conferred protection against age-
associated hippocampal atrophy, and that the effect was stronger in the left 
hippocampus (Firth et al., 2018). The conceptual model constructed in chapter one of 
this thesis also reflected potential intermediate pathways between PA undertaken 
earlier in adulthood and CF via reduction of cardiovascular risk, and PA occurring more 
proximally to CF measurement via psychological variables such as mood, anxiety and 
sleep.   
Other covariates  
Other factors which vary with PA and CF were systematically reviewed in chapter one 
of this thesis and synthesised to construct a conceptual model. There were a large 
number of confounders and mediators indicated by this process. Confounders broadly 
fell into the following categories: pre-birth factors (e.g., genetic risk); early life factors 
(e.g., childhood PA, education, traumatic events); adult sociodemographic factors 
(e.g., socioeconomic status, exposure to pollution); adult health behaviours (e.g., diet, 
alcohol consumption and smoking status); adult health outcomes (e.g., cardiovascular 
disease, neurological disease, mental health disorders); and medication (e.g., 
psychotropic or antihypertensive medication). Intermediates between baseline levels 
of PA and CF were brain health, sleep, anxiety and mood. Physical activity has long 
been associated with benefits for mental health (Ströhle, 2009), and evidence based 
interventions for depression such as behavioural activation can often cross over into 
PA either directly or indirectly (Lambert, Greaves, Farrand, Haase, & Taylor, 2017).  
Rationale for the present study  
As outlined in chapter one of this thesis, previous observational studies of the PA -CF 
relationship may be inaccurate because none have followed a comprehensive method 
to select covariates. The present study addressed this by using a graphical causal 
model to inform estimation of the total effect of PA on CF. Of 21 studies reviewed in 
chapter one, none performed formal mediation analysis to test potential intermediate 
mechanisms of the PA-CF relationship. The present study aimed to address this by 
considering potential mediation analysis to decompose any observed main effects into 
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direct and indirect effects, using the measures of brain health available within UK 
Biobank.  
Aims  
This study matched variables within the conceptual causal model reported in chapter 
one, with data available within the UK Biobank dataset, in order to address the 
following research aims:  
1)  To estimate the magnitude of the relationship between PA and CF in a cross-
sectional analysis of baseline UK Biobank data  
2) To estimate the magnitude of the relationship between PA at baseline and CF 
at follow-up in a longitudinal analysis  
3) To estimate the extent to which significant PA-CF relationships (if any) were 
mediated by structural brain differences   
Methods  
This study is reported according to the Strengthening Reporting of Observational 
Studies in Epidemiology (STROBE) statement (Von Elm et al., 2014).  
Participants  
UK Biobank is a very large prospective cohort study of over 500,000 participants 
designed to examine the genetic and environmental determinants of health in middle-
aged to older adults in the general population (Sudlow et al., 2015). Ethical approval 
was granted by the NHS Research Ethics Committee (appendix 2.1, p.107), and covers 
all studies relating to the resource. The present study was conducted under approved 
application 11332 (appendix 2.2, p.111).  NHS Lanarkshire’s R&D department was also 
notified that their employee was conducting this research, which was acknowledged 
by the health board (appendix 2.3, p.112).  
Participants provided written informed consent. Recruitment was based on proximity 
to an assessment centre and being within the eligible age range of 40-69. During the 
baseline assessment (2006-2010) participants attended assessment centres around 
the UK where they completed self-report sociodemographic, health and lifestyle 
questionnaires and an interview with a trained staff member, as well as undergoing 
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physical and biological measurements and a brief computerised cognitive assessment. 
Subsequently, a subset of the total cohort completed accelerometry (objective 
physical activity measures) and neuroimaging visits (including repeat cognitive 
assessments). Invitations to participate in accelerometry (2013-2015) (Doherty et al., 
2017) were sent to a random sample of participants with email addresses (excluding 
those closest to the main UK Biobank centre, due to concerns about burden on those 
participants). Invitations to the neuroimaging assessments (2014 onwards) were 
based on proximity to UK Biobank MRI scanning centres in England. Because the 
present study made use of genetic score data, the analysis sample was restricted to 
those with white British genetic ancestry (as determined centrally by UK Biobank 
based on a combination of self-report and genetic data) in order to reduce 
confounding induced by groups differing systematically both by genetic ancestry and 
according to phenotypic measures of interest (Turner et al., 2011). This type of 
restriction is standard practice and has been performed in UK Biobank studies 
previously (Milton et al., 2021). Similarly, the sample was restricted to unrelated 
people; this was done by randomly keeping one member of each related set (third 
degree or closer). Along with further standard exclusions based on genotyping quality 
control, this left a sample of 334,227 which was used for baseline analysis in the 










Figure 1: Flowchart showing participants included in the study  
Full cohort 
n = 502,485 
n = 408,152 
Not white British 
genetic ancestry 
n = 92,887 
n = 334,227 
Relatedness 
n = 73,925 
n = 409,598 
Genotyping quality 
control 




The variables within the conceptual model presented in chapter one were matched to 
the data available within UK Biobank (appendix 2.4, p.113).  
Exposure: baseline physical activity 
Self-report data: As part of the assessment centre visits, participants 
completed a modified form of the International Physical Activity Questionnaire 
(IPAQ) short form (Craig, etl.al., 2003), reporting the frequency and duration of 
walking, moderate and vigorous activity undertaken in a typical week. Data 
were processed in accordance with IPAQ scoring guidance, such that each 
category of activity was assigned the following weighting: walking, 3.3 METs, 
moderate activities, 4 METs and vigorous activities 8 METs. Total amount of 
moderate-vigorous PA was estimated as the sum of these moderate and 
vigorous PA expressed in MET hours per week, and classified as active if they 
met IPAQ recommendations of at least 10 MET hours per week of moderate to 
vigorous PA, as has been done in previous UK Biobank studies (Celis-Morales et 
al., 2019). 
Total PA was calculated by summing the weighted time spent across all three 
categories and expressed in MET-hours per week. Therefore, participants 
receive a total PA value if they had data for at least one of the three levels of 
activity.  
Accelerometer data: A subsample participated in accelerometer-measured PA 
data collection for a one-week period. The wrist-worn actigraph device 
recorded mean daily accelerations, expressed in milli-gravity per day, which 
was used as the objective measure of total PA (Doherty et al., 2017).  
Outcome: cognitive function 
Cognitive tests have been administered at several time-points to Biobank participants. 
These tests were developed specifically for Biobank, to enable computerised 
administration at scale without staff involvement, and are thus non-standardised. 
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However, the psychometric properties of these measures have since been compared 
to well-validated reference tests (Fawns-Ritchie & Deary, 2020). For the present study, 
the raw scores for all tests except prospective memory (as it is a binary variable) were 
converted into z-scores for ease of interpretation, standardised within five-year age 
bands at each assessment time-point. Therefore, the mean score is approximately 
zero, and the standard deviation for each is approximately one. For each z-score, 
higher scores represent better performance.  
Baseline CF  
During the original baseline assessment, almost all participants completed 
touchscreen tests of visuospatial memory (‘Pairs Matching’) and processing 
speed (‘Reaction Time’). Additional tests of prospective memory (‘Prospective 
Memory’), attention/working memory (‘Numeric Memory’), and verbal and 
numerical reasoning (‘Reasoning’) were added to the battery part way through 
the recruitment period, one of which (Numeric Memory) was subsequently 
removed for reasons of time. The sample sizes on these latter three tests are 
therefore smaller.  
- Reaction Time: Participants were shown pairs of cards on a screen and 
asked to press a button as quickly as possible when the two cards were 
identical. Twelve pairs were shown in total.  
- Pairs Matching: Participants were shown 12 cards onscreen simultaneously 
and were asked to recall the position of six matching pairs.  
- Reasoning: Participants were given two minutes to answer 13 multiple-
choice verbal and numerical reasoning questions. UK Biobank refers to this 
as a fluid intelligence test; however some questions require crystallised 
abilities, and thus the task has been described as a reasoning test here, in 
line with other studies (Lyall et al., 2016).  
- Numeric Memory: Participants were presented with a string of numbers 
onscreen, and asked to enter them on a keypad in reverse order from 
memory, following a brief delay. This test was intended to require 
participants to mentally reverse the numbers, making it similar to 
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backward digit span tasks. However, the stimuli were actually presented 
simultaneously rather than sequentially meaning the participants were 
able to achieve the correct response by recalling digit strings without 
reversing them if they read the numbers from right to left. This represents 
a forward digit span task which is an easier task, reflecting the 
attention/working memory domain.  
- Prospective Memory: Participants were presented with on-screen text 
informing them that at the end of the cognitive tests they would see four 
coloured symbols and be asked to touch the blue square. However, the 
instructions went on to inform the participant that they are to touch the 
orange circle instead. This required the participant to recall and respond in 
accordance with the true objective of the test.  
- Global CF: For the present study a composite measure of global CF was 
created by taking the mean of the four baseline z-scores, as has been done 
in previous studies (Halloway et al., 2017; Rajan et al., 2015; Sabia et al., 
2017). This score was only created for participants with two or more non-
missing z-score values.  
Follow-up CF  
The follow-up data in the present study pertains to ten tests administered at 
the imaging visit (the five described above plus five below).  
- Trail-making Test: Part A required participants to click on 25 numbered 
circles in ascending order, reflecting processing speed. Part B involved a 
similar task but switching between letters and numbers, reflecting 
processing speed plus executive function. Scores for each part reflect time 
taken in seconds to correctly click all circles. Additional scores comprising 
Part B time minus Part A time (as a more sensitive measure of executive 
function) and the number of errors made on part B were also derived.  
- Digit Symbol Substitution Test: A grid of eight symbols, each corresponding 
to a number, was displayed onscreen. Participants used a keypad to enter 
the number corresponding to each symbol as it was presented onscreen, 
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and scores reflect the total number of boxes correctly filled within two 
minutes. This task primarily reflects processing speed.  
- Tower Rearranging Test: Participants were presented with an onscreen 
illustration of three pegs, upon which three coloured hoops had been 
placed. They were then asked how many moves would be required to 
rearrange the hoops into another specified configuration. This test reflects 
executive function.  
- Paired Associate Learning: Participants were shown twelve pairs of words 
for 30 seconds in total, and after an interval presented with the first word 
for ten of these pairs and asked to select the matching word from lists of 
four alternatives. This test reflects verbal declarative memory.  
- Matrices: Participants were presented with a series of matrix pattern 
blocks with an element missing and asked to select the element that best 
completed the pattern from a range of specified choices. This test reflects 
non-verbal reasoning.  
One additional test (Picture Vocabulary) was administered at the imaging 
visits. Unfortunately, the data relating to this test have not yet been released 
by UK Biobank and so this is not described further here.  
Global CF: A composite measure of global CF was derived by taking the mean 
of ten imaging visit z-scores (trails B-A not included), for participants with at 
least two non-missing z-score values.  
Domain-level composites:  
As the imaging visit data included multiple tests that measure the same 
domain of CF, composite scores were derived using the mean of z-scores for 
participants who had at least two non-missing values for tests within that 
domain. The following domain-level composite scores were derived: 
processing speed (Digit Symbol Substitution and Reaction Time);  reasoning 
(Reasoning and Matrices); executive function (Tower Rearranging, Trails-A time 
and Trails-B time) and memory (Pairs Matching, Numeric Memory and Paired 




The intermediates of interest in this thesis pertained to brain health (although other 
pathways via mood, anxiety and sleep were also indicated by the model). All brain MRI 
data were acquired on a Siemens Skyra 3T scanner. The acquisition protocol is 
described in detail elsewhere 
https://biobank.ndph.ox.ac.uk/ukb/ukb/docs/brain_mri.pdf.  The variables of interest 
were determined by the systematic review reported in chapter one, and additional 
literature known to be relevant.  
Grey matter volume: Measures of interest which were available within UK 
Biobank were total grey matter volume as well as regional volumes of the left 
and right hippocampus, left and right dorsolateral prefrontal cortex 
(represented by the superior and middle frontal gyrus) and left and right 
anterior cingulate cortex.  
White matter: White matter measures of interest were total volume of 
hyperintensities, and a general factor representing tract integrity across 27 
bilateral white matter tracts (created using principal components analysis).  
Other covariates  
The covariates were identified by the graphical causal model reported in chapter one 
and matched to available UK Biobank data. These are described in appendix (2.5, 
p.116) and listed in full in table 1.  
Unmatched variables  
There were several variables within the conceptual model which could not be 
matched to data within UK Biobank. These were childhood PA, childhood IQ, earlier 
adulthood PA and cognitive activity. Of these, childhood PA and earlier adulthood PA 
were specified in all minimum covariate sets. Thus, the model estimated in this study 
represents the nearest approximation of the full conceptual model, as is 





All analyses were performed in Stata version 16. Data were summarised using 
descriptive statistics and displayed according to PA classification: active, inactive or 
missing. Normally distributed continuous variables are summarised as means and 
standard deviations, and skewed variables as medians with inter-quartile ranges. 
Ordinal and binary variables are reported as frequencies and percentages within each 
category. These summary statistics are presented for the baseline characteristics of 
the total sample, and the subsample who attended the imaging visit (table 1a). Data 
pertaining to the cognitive outcomes at follow-up are presented in table 1b. 
Differences between the PA groups for each measure were not formally tested, as the 
decision about entering covariates into the regression models was based a priori on 
the DAG rather than on the existence of statistical differences. The relationship 
between PA and CF was then estimated using two sets of regression models.  
The first set of regression models (table 2) used CF data that was measured cross-
sectionally with the PA measure.  Cognitive scores at baseline were entered as the 
dependent variable and total self-reported PA in MET hours per week, as a continuous 
independent variable. Models were initially run without adjustment, and then 
adjusted according to the nearest approximation of the minimum sufficient 
adjustment set (listed below table 2).  
The second set of regression models (table 3) used the CF variables pertaining to the 
imaging visit, making the analysis longitudinal by design. The included covariates were 
as above with the addition of follow-up duration, and both self-reported PA and the 
covariate values were again taken from baseline data. This set of models was also 
repeated using accelerometery data as an objective measure of PA (which was 
acquired after baseline CF measurement and thus not used in cross sectional models).  
Diagnostic checks were performed for all models to ensure the assumptions for 
regression were met. False discovery rate correction of the p values was used to 
minimise the rate of false positive significant results within groups of models that 
tested the same hypotheses, with the corrected significance level set at 0.05.   
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Where the above total effects models for CF at follow-up (imaging visit) showed a 
significant relationship between PA and CF, it was planned that mediation models 
would be conducted to estimate the magnitude of the effect that was transmitted via 
structural brain MRI measures; these models would be adjusted for confounders of 
the relationships between PA, CF and the mediators, as determined from the DAG.  




Table 1a shows descriptive statistics for the variables specified in the conceptual 
model at baseline for both the entire sample, and for the subsample who returned for 
imaging. The subsample who returned for imaging were on average younger, more 
active, less deprived, and generally healthier at baseline than the overall sample. It is 
also apparent that, within the baseline data, those who were missing PA status were 
less educated, more deprived, and generally less healthy than the overall sample, 
suggesting that missingness on the moderate-vigorous PA measures (which 
determined the PA groups) was not random. High missingness on some cognitive tests 
reflects that some tests were introduced at different stages within the baseline 
recruitment window. Table 1b shows the cognitive outcomes for the imaging sample 
at follow-up. Generally, the descriptive statistics suggested very small reductions in CF, 
of similar magnitude across the PA groups. The mean duration between baseline and 
follow-up was 8.94 years (SD 1.76).  
Effect of physical activity on cognitive function at baseline  
Table 2 shows the cross-sectional regression results estimating the effect of PA, 
expressed in MET hours per week, on CF, expressed in z-score units (with the 
exception of Prospective Memory, which is an odds ratio reflecting the odds of a 
correct response). Missing values throughout the dataset resulted in different sample 
sizes for analysis. For baseline analyses sample sizes ranged from 31,854 (Numeric 
Memory) to 305,294 (Reaction Time) in unadjusted models. Adjusted model sample 
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sizes ranged from 2,548 (Prospective Memory) to 29,810 (Reaction Time). The 
unadjusted models indicated a statistically significant, but trivially small, effect of PA 
on CF. For each measure of CF, the direction of the effect was negative (harmful), 
except for Reaction Time which was positive (protective). When models were adjusted 
for covariates, the effects were no longer significant except for Reasoning, which 
remained significant and still of very small magnitude. 
Effect of physical activity on cognitive function at follow-up  
Table 3 displays the longitudinal regression results estimating the effect of self-
reported PA, expressed in MET hours per week, on CF, expressed in z-score units (with 
the exception of Prospective Memory, which is an odds ratio reflecting the odds of a 
correct response). Results for the same models repeated using accelerometery 
averages (expressed in milligravity units) as a continuous measure of objectively 
measured PA, are displayed in the lower half of the same table.   
For self-reported PA, unadjusted longitudinal model sample sizes ranged from 21,225 
(Trails-B Time) to 30,330 (Prospective Memory).  Across the unadjusted self-reported 
PA models the estimated effect of PA on CF was trivially small, albeit statistically 
significant (except in the case of Reaction Time which was non-significant). The 
direction of the effect was negative (harmful) for all CF measures.  After adjusting the 
models for the specified covariates, sample sizes ranged from 4,805 (Paired Associate 
Learning) to 6,840 (Prospective Memory). Outcomes which remained significant 
following adjustment were Reasoning (individual tests and composite measure), Trails 
(B time, B-A time and B errors) and the composite Executive Function measure, and 
the Memory and Global composites. All of these effects were trivially small in 
magnitude, and in the negative direction.  
For objectively measured PA, sample sizes for unadjusted models ranged from 9,362 
(Trails-B errors) to 14,392 (Prospective Memory). There were trivially small but 
significant effects in unadjusted models for Reaction Time, Symbol Digit Substitution,  
Trails A time, and the Processing Speed composite, all in the positive (protective) 
direction. After adjusting for the specified covariates, sample sizes ranged from 2,742 
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(Trails-B Time) to 3,935 (Reaction Time). The effect size estimates remained trivially 
small, and none were statistically significant.  
Mediating pathways  
Given that the results from the follow-up models were inconsistent in direction and 
with very small effect sizes, it was decided that mediation analysis would not be 
conducted.  
Sensitivity analysis  
Because the adjusted models contained large numbers of covariates, results were 
potentially sensitive to bias arising from missing data. To examine this possibility a 
sensitivity analysis was performed by repeating the unadjusted analyses, restricted to 
those participants who had full covariate data. The results are presented in appendix 
2.6 (p.118). There was very little difference in effect estimates, indicating that the 
unadjusted relationship between PA and CF was very similar among people with and 
without missing covariate data. Therefore, it is unlikely that observed results in 











Table 1a: Baseline characteristics of total sample and the imaging sub-sample  
 Total sample  Active (≥10 MET 
hours 
mvPA/week)   
Inactive (<10 
MET hours of 
mvPA/week)   
Missing PA 
statusa 
 Total sample  Active (≥10 MET 
hours 
mvPA/week)   
Inactive (<10 
MET hours of 
mvPA/week)   
Missing PA 
statusa 
Total sample   Imaging sub-sample (at baseline)  
n (%) of sample)  334,227 
(100.00) 
181,587 (54.33)  82,917 (24.81)  69,723 (20.86) 34,058 
(100.00)  
19,495 (57.24)  9,175 (26.94)  5,338 (15.82)  
Demographics  Demographics 









57.46 (7.70)  
 
55.46 (7.50)  
 
55.57 (7.64)  
 
55.30 (7.28)  
 
55.35 (7.31)  
Sex 








40,594 (58.22)  
 
17,317 (50.85)  
 
9,598 (49.23)  
 
4,682 (51.03)  
 
3,037 (56.37)  
Physical activity Physical activity 
Acceleration 
average 
(milligravity units)  
n (%) missing  














63,969 (77.15)  




57,937 (83.10)  




18,837 (55.31)  




10,606 (54.40)  




5,187 (56.53)  




5,388 (56.50)  
26.08 (7.91)  
 mvPA, self-report 
(MET hrs/week) 
n (%) missing  
Median  
(Q1, Q3)  
 
 
69,723 (20.86)  
18.67  
(8.00, 40.00)  
 
 
0 (0)  
30.00  
(18.00, 56.00)  
 
  
0 (0)  
4.00  
(2.00, 6.67)  
 
 




5,388 (15.82)  
18.00  
(7.33, 36)  
 
 
0 (0)  
28.00  
(17.33, 36.00)  
 
 
0 (0)  
4.00  
(2.00, 6.67)  
 
 












27,310 (8.17)  
28.22  








0 (0)  
47.55 




0 (0)  
11.90 




27,310 (39.17)  
8.25 




1,803 (5.29)  
27.55  




0 (0)  
43.62 





0 (0)  
11.70  




1,803 (33.46)  
7.70 
(3.30, 15.40)  
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 Total sample  Active (≥10 MET 
hours 
mvPA/week)   
Inactive (<10 
MET hours of 
mvPA/week)   
Missing PA 
statusa 
 Total sample  Active (≥10 MET 
hours 
mvPA/week)   
Inactive (<10 
MET hours of 




Cognitive function (baseline tests)  
 
 
Cognitive function (baseline tests in imaging subsample) 
Numeric memory 
(Z score)  





-0.35 (0.94)  
 
 
161,673 (89.03)  




- 0.27 (0.93)  
 
 
63,340 (90.85)  




-0.18 (0.93)   
 
 
17,460 (89.56)  








-0.20 (0.93)   
Pairs matching (Z 
score)  
n (%) missing  
Mean (SD)  
 
 
7,550 (2.26)  




0.23 (1.04)  
 
 
1,472 (1.78)  
0.27 (1.03)  
 
 
2,693 (3.86)  
0.22 (1.04)  
 
 
446 (1.31)  
0.32 (1.03)  
 
 
179 (0.92)  
0.31 (1.03)  
 
 
70 (0.76)  
0.33 (1.03)  
 
 
197 (3.66)  
0.35 (1.01)  
Prospective 
memory 
n (%) missing  
n (%) correct on 
first attempt  
 
 
223,812 (66.96)  









22,505 (83.03)  
 
 
48,330 (69.32)  




8,551 (87.68)  
 
 
12,831 (65.82)  
5,809 (86.73)  
 
 
9,175 (66.79)  
2,742 (89.75)  
 
 
3,730 (69.23)  
1,492 (85.21)  
Reaction time (Z 
score)  
n (%) missing 
Mean (SD)  
 
 
2,010 (0.60)  
0.05 (0.95)  
 
 
849 (0.47)  
0.08 (0.94)  
 
 
427 (0.51)  
0.06 (0.94)  
 
 
734 (1.05)  
-0.02 (0.96)  
 
 
65 (0.19)  
0.16 (0.93)  
 
 
25 (0.13)  
0.18 (0.92)  
 
 
18 (0.20)  
0.14 (0.92)  
 
 
22 (0.41)  
0.11 (0.93)  
Reasoning (Z 
score)  




1,363 (1.24)  
-0.13 (0.94)  
 
 
646 (1.05)  
-0.13 (0.93)  
 
 
226 (0.84)  
0.01 (0.93)  
 
 
491 (2.33)  








0.10 (0.90)   
 
 




3,730 (69.23)  
0.08 (0.90)  
Global CFb (Z 
score)  
n (%) missing  
Mean (SD)  
 
 
7,540 (2.26)  
0.11 (0.70)  
 
 
3,324 (1.83)  
0.11 (0.69)  
 
 
1,462 (1.76)  
0.14 (0.69)  
 
 
2,754 (3.95)  
0.05 (0.71)  
 
 
2,370 (6.96)  
-0.06 (0.46)  
 
 
1,407 (7.22)  
- 0.06 (0.46)  
 
 
539 (5.87)  
-0.03 (0.45)  
 
 
424 (7.87)  




 Total sample  Active (≥10 MET 
hours 
mvPA/week)   
Inactive (<10 
MET hours of 
mvPA/week)   
Missing PA 
statusa 
 Total sample  Active (≥10 MET 
hours 
mvPA/week)   
Inactive (<10 
MET hours of 
mvPA/week)   
Missing PA 
statusa 
APOE genotype  
n (%) missing  
n (%) with each 
number of APOE 









237,761 (71.14)  
88,276 (26.44)  






128,621 (70.83)  
48,461 (26.69)  







21,703 (26.17)  






49,913 (71.59)  







24,527 (72.02)  
8,754 (25.70)  
777 (2.28)  
 




14,036 (72.00)  
4,998 (25.64)  
461 (2.36)  
 




6,623 (72.19)  
2,343 (25.54)  
209 (2.08)  
 




3,868 (71.79)  
1,413 (26.22)  
107 (1.99)  
Polygenic 
dementia risk 
score (Z score)  
n (%) missing 














242 (0.29)  




213 (0.31)  




113 (0.33)  




65 (0.33)  




31 (0.34)  




17 (0.32)  
-0.01 (1.00)  
Familial risk Familial risk 
Dementia (parent 
or sibling with 
diagnosis)  
n (%) missing  
n (%) with 









24,599 (13.55)  









13,263 (19.02)  




3,954 (11.61)  




2,198 (11.27)  




1,023 (11.15)  




733 (13.60)  




n (%) missing  





46,978 (14.06)  




24,009 (13.22)  









11,755 (16.86)  




4,127 (12.12)  




2,281 (11.70)  




1,079 (11.76)  




767 (14.24)  
1,489 (27.64)  
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 Total sample  Active (≥10 MET 
hours 
mvPA/week)   
Inactive (<10 
MET hours of 
mvPA/week)   
Missing PA 
statusa 
 Total sample  Active (≥10 MET 
hours 
mvPA/week)   
Inactive (<10 
MET hours of 




disease (parent or 
sibling with 
diagnosis)  
n (%) missing  
n (%) with 





53,562 (16.03)  





26,860 (14.79)  





12,045 (14.53)  





14,657 (21.02)  





4,205 (12.35)  





2,289 (11.74)  











835 (15.50)  
211 (3.92)  
Sociodemographic Sociodemographic 
Acculturation 
(years in UK)  
n (%) missing 




















64.00)   
 
 
0 (0)  
56.00 
(49.00, 61.00)  
 
 















n (%) missing 





















15,465 (22.18)  
 
 
226 (0.66)  
 
15,524 (45.58)  
 
 
46 (0.24)  
 
8,991 (46.12)  
 
 
13 (0.14)  
 
4,579 (49.91)  
 
 
167 (3.10)  
 
1,954 (36.27)  
Household 
income  
n (%) missing  
n (%) in each 
income category   
< £18k 
£18k - £30,999 
£31k – £51,999 







62,329 (18.65)  
73,830 (22.09)  
76,417 (22.86)  
59,938 (17.93)  
15,586 (4.66)   
 
 
22,274 (12.27)  
 
 
32,501 (17.90)  
41,779 (23.01)  
42,474 (23.39)  
33,266 (18.32)  
9,294 (5.12)  
 
 
8,930 (10.77)  
 
 
13,772 (16.61)  
17,902 (21.59)  
20,447 (24.66)  
17,436 (21.03)  
4,430 (5.34)  
 
 
14,923 (21.40)  
 
 
16,056 (23.03)  
14,150 (20.29)  
13,496 (19.36)  








6.992 (20.53)  
9,401 (27.60)  
9,787 (25.80)  
2,369 (6.96)  
 
 
1,566 (8.03)  
 
 
2,072 (10.63)  
4,083 (20.94)  
5,377 (27.58)  
4,893 (25.56)  
1,414 (7.25)  
 
 




1,853 (20.20)  
2,557 (27.87)  
2,615 (28.50)  
695 (7.57)  
 
 
785 (14.57)  
 
 
631 (11.71)  
1,056 (19.60)  
1,467 (27.23)  
1,189 (22.07)  
260 (4.83)  
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 Total sample  Active (≥10 MET 
hours 
mvPA/week)   
Inactive (<10 
MET hours of 
mvPA/week)   
Missing PA 
statusa 
 Total sample  Active (≥10 MET 
hours 
mvPA/week)   
Inactive (<10 
MET hours of 
mvPA/week)   
Missing PA 
statusa 
Living alone  
n (%) missing  
n (%) answered 
yes 
 
981 (0.29)  
60,558 (18.12)  
 
464 (0.26)  
31,583 (17.39)  
 
190 (0.23)  
15,016 (18.11)  
 
327 (0.47)  
13,959 (20.02) 
 
51 (0.15)  
5,162 (15.16)  
 
24 (0.12)  
2,904 (14.90)  
 
11 (0.12)  
1,410 (15.37)  
 
16 (0.30) 
848 (15.74)  
Married  
n (%) missing  




247,610 (74.08)  
 
464 (0.26)  
136,554 (75.20)  
 
191 (0.23)  
61,596 (74.29)  
 
299 (0.43)  
49,460 (74.08)  
 
56 (0.16)  
26,614 (78.14)  
 
27 (0.14)  
15,281 (78.38)  
 
12 (0.13) 
7,199 (78.46)  
 
17 (0.32)  
4,134 (76.74)  
Pollution (inverse 
distance to major 
road)  
n (%) missing  
n (%) in each 
















70,159 (20.99)  
66,726 (19.96)  
64,998 (19.45)  
64,364 (19.26)  









38,825 (21.38)  
36,220 (19.95)  
35,267 (19.42)  
34,790 (19.16)  









17,428 (21.02)  
16,570 (19.98)  
15,923 (19.20) 
15,942 (19.23)  









13,906 (19.94)  
13,936 (19.99)  
13,808 (19.80)  
13,632 (19.55)  









6,985 (20.51)  
6,810 (20.00)  
6,423 (18.86)  










4,057 (20.81)  
3,920 (20.11)  
3,638 (18.66)  
3,899 (20.00)  









1,864 (20.32)  
1,834 (19.99)  
1,730 (18.86)  
1,836 (20.01)  









1,064 (19.75)  
1,056 (19.60)  
1,055 (19.58)  
1,005 (18.65)  
1,136 (21.08)  
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 Total sample  Active (≥10 MET 
hours 
mvPA/week)   
Inactive (<10 
MET hours of 
mvPA/week)   
Missing PA 
statusa 
 Total sample  Active (≥10 MET 
hours 
mvPA/week)   
Inactive (<10 
MET hours of 







n (%) missing  
n (%) in each 
category  
Almost daily  
2-4 times/week  
About once a 
week  
About once a 
month  
Once every few 
months  









1,926 (0.58)  
 
 
39,054 (11.68)  
104,315 (31.21)  
118,650 (35.50)  
 
43,841 (13.12)  
 









540 (0.30)  
 
 
21,950 (11.89)  
58,435 (32.18)  
64, 863 (35.72)  
 
23,108 (12.73)  
 
10,717 (5.90)  
 
2,093 (1.15)  
 





219 (0.26)  
 
 
8,534 (10.29)  
25,277 (30.48) 
30,449 (36.72)  
 
11,937 (14.40)  
 
5,399 (6.51)  
 
973 (1.17)  
 





1,167 (1.67)  
 
 
8,930 (12.81)  
20,603 (29.55)  
23,338 (33.47)  
 
8,796 (12.62)  
 
5,136 (7.37)  
 
1,515 (2.17)  
 







208 (0.61)  
 
 
3,244 (9.52)  
10,162 (29.84)  
12,804 (37.59)  
 
14,86 (5,060  
 
2,233 (6.56)  
 
322 (0.95)  
 





28 (0.14)  
 
 
1,942 (9.96)  
6,081 (31.19)  
7,270 (37.29)  
 
2,794 (14.33)  
 
1,219 (6.25)  
 
154 (0.79)  
 





7 (0.08)  
 
 
766 (8.35)  
2,650 (28.88)  
3,609 (39.34)  
 
1,455 (15.86)  
 
607 (6.62)  
 
73 (0.80)  
 





173 (3.21)  
 
 
536 (9.95)  
1,431 (26.56)  
1,925 (35.73)  
 
811 (15.05)  
 
407 (7.55)  
 
85 (1.76)  
 
10 (0.19)  
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 Total sample  Active (≥10 MET 
hours 
mvPA/week)   
Inactive (<10 
MET hours of 
mvPA/week)   
Missing PA 
statusa 
 Total sample  Active (≥10 MET 
hours 
mvPA/week)   
Inactive (<10 
MET hours of 





quintiles (Q1 = 
least deprived)  
n (%) missing 














72,601 (21.72)  
70,937 (21.22)  
68,974 (20.64)  
64,640 (19.34)  








40,813 (22.48)  
39,614 (21.82)  
37,969 (20.91)  
34,748 (19.14)  





110 (0.13)  
 
 
18,626 (22.46)  
17,778 (21.44)  
17,106 (20.63)  
16,005 (19.30)  









13,545 (19.43)  
13,899 (19.93)  
13,887 (19.92)  






30 (0.09)  
 
 
8,505 (24.97)  
8,092 (23.76)  
7,058 (20.72)  
6,125 (17.98)  









4,636 (23.78)  
4,128 (21.17)  
3,446 (17.68)  





11 (0.12)  
 
 
2,354 (25.66)  
2,217 (24.16) 
1,836 (20.01)  
1,679 (18.30)  





1 (0.02)  
 
 
1,289 (23.92)  
1,239 (23.00)  
1,094 (20.30)  
1,000 (18.56)  
765 (14.20)  





n (%) missing 













233,298 (69.80)  
 
 
 50,329 (49.87)  
24,772 (24.54)  
 
8,998 (8.92)  
13,304 (13.18)  








27,890 (49.01)  
14,030 (24.65)  
 
5,287 (9.29)  
7,835 (13.77)  






55,235 (66.61)  
 
 
13,688 (49.45)  
6,978 (25.21)  
 
2,492 (9.00)  
3,513 (12.69)  








8,751 (53.57)  
3,764 (23.04)  
 
1,219 (7.46)  
1,956 (11.97)  









10,214 (29.99)  
5,760 (16.91)  
 
2,122 (6.23)  
3,146 (9.24)  





6,847 (35.12)  
 
 
5,800 (29.75)  
3,273 (16.79)  
 
1,275 (6.54) 
1,895 (9.72)  





3,183 (34.69)  
 
 
2,741 (29.87)  
1,640 (17.87)  
 
566 (6.17)  
818 (8.92)  





2,023 (37.55)  
 
 
1,673 (31.05)  
847 (15.72)  
 
281 (5.22)  
433 (8.04)  
131 (2.43)  
Alcohol 
frequency  





99 (0.05)  
 
 
39 (0.05)  
 
 
152 (0.22)  
 
 
6 (0.02)  
 
 
3 (0.02)  
 
 
1 (0.01)  
 
 




 Total sample  Active (≥10 MET 
hours 
mvPA/week)   
Inactive (<10 
MET hours of 
mvPA/week)   
Missing PA 
statusa 
 Total sample  Active (≥10 MET 
hours 
mvPA/week)   
Inactive (<10 
MET hours of 
mvPA/week)   
Missing PA 
statusa 
n (%) in each 
category 
Daily/almost daily 
3-4 times per 
week 
1-2 times per 
week  




Never   
 
 
71,942 (21.52)  
80,933 (24.23)  
 
87,653 (26.23)  
 
36,751 (11.00)  
 
34,947 (10.46)  
11,378 (3.40)  
10,273 (3.07)  
 
 
40,332 (22.21)  




18,870 (10.39)  
 
16, 716 (9.21)  
5,460 (3.01)  
3,048 (4.37)  
 
 
18,523 (22.34)  
20,272 (24.45)  
 
21,469 (25.89)  
 
9,405 (25.89)  
 
8,401 (10.13)  
2,491 (3.00)  
2,317 (2.79)  
 
 
13,087 (18.77)  
13,805 (19.80  
 
17,898 (25.67)  
 
8,476 (12.16)  
 
9,830 (14.10) 
3,427 (4.92)  
3,048 (4.37)  
 
 
8,092 (23.76)  
9,816 (28.82)  
 
8,660 (25.43)  
 
3,520 (10.34)  
 
2,552 (7.49)  
714 (2.10)   
698 (2.05)  
 
 
4,600 (23.60)  
5,941 (30.47)  
 
5,000 (25.65)  
 
1,885 (9.67)  
 
1,300 (6.67)  




2,289 (24.95)  
2,563 (27.93)  
 
2,314 (25.22)  
 
967 (10.54)  
 
686 (7.48)  
175 (1.91)  




1,212 (24.35)  
 
1,346 (24.98)  
 
668 (12.40  
 
566 (10.50)  
143 (2.65)  
148 (2.75)  
Energy intake (KJ 
on previous day)  



















44,776 (64.22)  
8645 (2975.42)  
 
 















2,109 (39.14)  
8712.32 
(2820.03)  
Salt intake (added 
to food)  
n (%) missing  








37 (0.01)  
 
 
189,549 (56.71)  
92,412 (27.65)  
37,826 (11.32)  
14,403 (4.31)  
 
 
9 (0.00)  
 
 
104,889 (57.76)  
49,925 (27.49)  
19,820 (10.91)  
6,944 (3.82)  
 
 
10 (0.01)  
 
 
47,369 (57.13)  
22,985 (27.72)  
9,335 (11.26)  
3,218 (3.88)  
 
 
18 (0.03)  
 
 
37,291 (53.48)  
19,502 (27.97)  
8,671 (12.44)  
4,241 (6.08)  
 
 
1 (0.01)  
 
 
20,621 (60.55)  
8,940 (26.25)  
3,516 (10.32)  
980 (2.88)  
 
 
1 (0.01)  
 
 
11,949 (61.29)  
5,065 (25.98)  
1,963 (10.07)  
518 (2.66)  
 
 
0 (0)  
 
 
5,567 (60.68)  
2,403 (26.19)  
938 (10.22)  






3,105 (57.63)  
1,472 (27.32)  
615 (11.41)  
196 (3.64)  
Smoking status 
n (%) missing 
Ever smoker, n 









36,504 (44.02)  
 
460 (0.66)  
33,292 (47.75)  
 
65 (0.19)  
13,376 (39.27)  
 
31 (0.16)  
7,787 (39.94)  
 
13 (0.14)  
3,457 (37,68)  
 
21 (0.39)  
2,132 (39.57)  
Cardiovascular risk and biomarkers Cardiovascular risk and biomarkers 
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 Total sample  Active (≥10 MET 
hours 
mvPA/week)   
Inactive (<10 
MET hours of 
mvPA/week)   
Missing PA 
statusa 
 Total sample  Active (≥10 MET 
hours 
mvPA/week)   
Inactive (<10 
MET hours of 
mvPA/week)   
Missing PA 
statusa 
Adiposity (BMI)  
n (%) missing 
Mean (SD)  
 
1,080 (0.32) 
27.39 (4.75)  
 
391 (0.22) 
26.85 (4.33)  
 
219 (0.26) 
27.65 (4.86)  
 
470 (0.67) 
28.49 (5.42)  
 
38 (0.11)  
26.63 (4.26)  
 
26 (0.13)  
26.22 (3.94)  
 
6 (0.07)  
26.90 (4.42)  
 
6 (0.11)  
27.62 (4.84)  
Adiposity (waist 
circumference, 
cm)   
n (%) missing  




563 (0.17)  




214 (0.12)  




118 (0.14)  









13 (0.04)  




8 (0.04)  




4 (0.04)  




1 (0.02)  
90.51 (13.60)  
Arterial stiffness 
(stiffness index, 
higher = stiffer)  
n (%) missing  










120,413 (66.31)  
8.95 




56,120 (67.68)  
9.11  




48,582 (69.68)  
9.30 


























n (%) missing 






2.38 (0.09)  
 
10,513 (12.68)  
2.38 (0.09)  
 
9,008 (12.92)  
2.38 (0.10)  
 
4,496 (13.20)  
2.38 (0.10)  
 
2,551 (13.09)  
2.38 (0.09)  
 
1,141 (12.44)  
2.37 (0.09)  
 
804 (14.92)  
2.38 (0.09)  
Total cholesterol 
(mmol/L)  













5.71 (1.15)  
 
 
3,542 (5.08)  
5.69 (1.19)  
 
 
1,666 (4.89)  
5.72 (1.09)  
 
 
877 (4.50)  
5.72 (1.08)  
 
 
5,388 (6.83)  
5.72 (1.10)  
 
 
368 (6.83)  
5.74 (1.09)  
Diastolic BP 
(mmHg) 








11,684 (6.43)  
82.00 (10.58)  
 
 
5.386 (6.50)  
82.42 (10.70)  
 
 
4,984 (7.15)  




81.52 (10.42)   
 
 
1,231 (6.31)  
81.20 (10.30)  
 
 
585 (6.38)  
81.80 (10.45)  
 
 
411 (7.63)  
82.17 (10.70)  
Inflammation, 
CRP (mg/L) 
n (%) missing 










2.40)   
 
 





3,697 (5.30)  





2.17)   
 
 










385 (7.15)  
1.32 (0.66, 2.69)  
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 Total sample  Active (≥10 MET 
hours 
mvPA/week)   
Inactive (<10 
MET hours of 
mvPA/week)   
Missing PA 
statusa 
 Total sample  Active (≥10 MET 
hours 
mvPA/week)   
Inactive (<10 
MET hours of 





n (%) missing  
Mean (SD)  
 
 
22,059 (6.60)  
140.15 (19.65)  
 
 
11,687 (6.44)  
140.13 (19.64)  
 
 
5,387 (6.50)  
139.37 (19.52)  
 
 
4,985 (7.15)  




137.52 (18.85)    
 
 
1,231 (6.31)  
137 (18.85)   
 
 
585 (6.38)  
136.88 (18.65)   
 
 
411 (7.63)  
137.52 (18.85)   
Medical diagnoses Medical diagnoses 
Atrial fibrillation  
n (%) missing  
n (%) with 
diagnosis  
 
0 (0)  
5,822 (1.74)  
 
0 (0) 
2,919 (1.61)  
 
0 (0) 
1,479 (1.78)  
 
0 (0) 
1,424 (2.04)  
 
0 (0)  
433 (1.27)  
 
0 (0) 
246 (1.26)  
 
0 (0)  
114 (1.24)  
 
0 (0)  
73 (1.35)  
Cardiovascular 
disease  
n (%) missing  

















8,014 (11.49)      
 
 
0 (0)  
2,197 (6.45)  
 
 
0 (0)  
1,218 (6.25)  
 
 
0 (0)  
611 (6.66)  
 
 
0 (0)  
367 (6.81)  
Cerebrovascular 
disease  
n (%) missing  

















1,721 (2.47)     
 
 
0 (0)  
307 (0.90)  
 
 
0 (0)  
154 (0.79)  
 
 
0 (0)  
92 (1.00)  
 
 
0 (0)  
61 (1.13)  
Chronic kidney 
disease  
n (%) missing  

















1,147 (1.16)    
 
 
0 (0)  
261 (0.77)  
 
 
0 (0)  




66 (0.72)  
 
 
0 (0)  
53 (0.98)  
Chronic lung 
disease  
n (%) missing  

















1,395 (2.00)   
 
 
0 (0)  
160 (0.47)  
 
 
0 (0)  
75 (0.38)  
 
 
0 (0)  
39 (0.43)  
 
 
0 (0)  
46 (0.85)  
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 Total sample  Active (≥10 MET 
hours 
mvPA/week)   
Inactive (<10 
MET hours of 
mvPA/week)   
Missing PA 
statusa 
 Total sample  Active (≥10 MET 
hours 
mvPA/week)   
Inactive (<10 
MET hours of 




n (%) missing  




45 (0.01)     
 
0 (0) 
20 (0.01)  
 
0 (0) 
13 (0.02)  
 
0 (0) 
12 (0.02)       
 
0 (0)  
0 (0)  
 
0 (0)  
0 (0)  
 
0 (0)  
0 (0)  
 
0 (0)  
0 (0)  
Diabetes   
n (%) missing  




15,890 (4.75)    
 
0 (0) 
6,934 (3.82)  
 
0 (0) 
4,090 (4.93)    
 
0 (0) 
4,866 (6.98)    
 
0 (0)  
992 (2.91)  
 
0 (0)  
447 (2.29) 
 
0 (0)  
302 (3.29)  
 
0 (0)  
243 (4.51)  
Head injury  
n (%) missing  










325 (0.39)  
 
0 (0) 
337 (0.44)  
 
0 (0)  
95 (0.28)  
 
0 (0)  
54 (0.28)   
 
0 (0)  
27 (0.29)  
 
0 (0)  
14 (0.26)  
Mood disorder  
n (%) missing  




28,940 (8.66)     
 
0 (0) 
13,777 (7.59)  
 
0 (0) 
7,412 (8.94)      
 
0 (0) 
7,751 (11.12)      
 
0 (0)  
3,376 (9.91)  
 
0 (0)  
1,726 (8.85)  
 
0 (0)  
961 (10.47)  
 
0 (0)  
689 (12.79)  
Musculoskeletal 
condition  
n (%) missing  

















33,480 (48.02)     
 
 
0 (0)  
14,132 (41.49)  
 
 
0 (0)  
8,136 (41.73)  
 
 
0 (0)  
3,713 (40.47)  
 
 
0 (0)  
2,283 (42.37)   
Neurological 
condition  
n (%) missing  

















12,652 (18.15)  
 
 
0 (0)  
5,138 (15.09)  
 
 
0 (0)  
2,744 (14.08)  
 
 
0 (0)  
1,455 (15.86)   
 
 
0 (0)  
939 (17.43)    
Psychotic 
conditions 
n (%) missing  

















272 (0.39)       
 
 
0 (0)  
31 (0.09)   
 
 
0 (0)  
21 (0.11)   
 
 
0 (0)  
7 (0.08)    
 
 
0 (0)  
3 (0.06)     
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 Total sample  Active (≥10 MET 
hours 
mvPA/week)   
Inactive (<10 
MET hours of 
mvPA/week)   
Missing PA 
statusa 
 Total sample  Active (≥10 MET 
hours 
mvPA/week)   
Inactive (<10 
MET hours of 
mvPA/week)   
Missing PA 
statusa 
Mental health  Mental health 
Current 
depression score  
n (%) missing  
Median  
 (Q1, Q3)   
 
 
31,179 (9.33)  




13,661 (7.52)  




1.62 (2.03)  
 
 
10,949 (15.70)  


















529 (9.82)  
1.00 (0.00, 3.00) 
Neuroticism 
score  
n (%) missing  
Median  
 (Q1, Q3)   
 
62,404 (18.67)  
4.10 (3.25)  
 
29,652 (16.33)  
3.91 (3.20)  
 
14,363 (17.32)  
4.18 (3.23)  
 
18,389 (26.37)  
4.56 (3.40)  
 












1,109 (20.58)  
3.00 (1.00, 7.00) 
Traumatic events 
n (%) missing  
n (%) with ≥1 
traumatic events  
 
225,491 (67.47)  
49,491 (45.51)  
 
 
120,692 (66.47)  
27,690 (45.47)  
 
53,243 (64.21)  
13,286 (44.77)  
 
51,556 (74.94)  
8,515 (46.87)  
 
 
10,687 (31.38)  
10,564 (31.02)  
 
6,146 (31.53)  
6,081 (31.19)  
 
 




1,733 (32.16)  
1.674 (31.07)  
Worrier status  
n (%) missing  
n (%) answered 
yes  
 
8,382 (2.51)  
184,878 (55.32)  
 
3,964 (2.18) 
97,082 (53.46)  
 
1,915 (2.31)  
46,738 (56.37)  
 
2,503 (3.59)  
41,058 (58.89)  
 
730 (2.14)  
17,496 (51.37)  
 
386 (1.98)  
9,639 (49.44)  
 
194 (2.11)  
4,848 (52.84)  
 
150 (2.78)  




n (%) missing 








34,004 (18.73)  
 
 





1,010 (1.45)  
18,052 (25.89)  
 
 
272 (0.80)  
4,210 (12.36)  
 
 
76 (0.39)  
2,258 (11.58)  
 
 
33 (0.36)  
1.170 (12.75)  
 
 
163 (3.03)  
782 (14.51)  
Psychotropic 
medication 
n (%) missing 








12,687 (6.99)  
 
 
2,408 (2.90)  
7,158 (8.63)  
 
 




942 (2.77)  
1,957 (5.75)  
 
 
519 (2.66)  
932 (4.78)  
 
 
262 (2.86)  
528 (5.75)  
 
 
161 (2.99)  
497 (9.22)  
Abbreviations: BMI, Body Mass Index; BP, blood pressure; CF, cognitive function; cm, centimetres; CRP, C-reactive protein; KJ, kilojoules; MET, Metabolic Equivalent of Task; mg/L, milligrams 
per litre; mmHg, millimeters of mercury; mmol/L, millimoles per litre; mvPA, moderate-vigorous PA; PA , physical activity; Q, quartile; Qu, Quintile; SD, Standard deviation 
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Footnotes for table: 
a: Individuals were classified as active if they met ≥10 MET hours of moderate to vigorous PA per week. However, they also reported levels of light PA (walking) which did not contribute to 
this classification. Total PA includes light PA as well as mvPA. Therefore, there is a subset of individuals who are non-missing on light PA, but missing on both moderate and vigorous PA. These 
individuals will have a value for total PA but be counted as missing PA classification. 
b: Global CF = mean of z scores on four tests (assuming at least two non-missing values) 
c: Medical diagnoses based on linked health records with positive diagnosis indicating diagnosis on or before baseline assessment date 
Table 1b: Cognitive outcomes for imaging subsample at follow-up   
 Total sample  Active (≥10 
MET hours 
mvPA/week)   
Inactive (<10 
MET hours of 
mvPA/week)   
Missing PA 
statusa 
n (%) of sample) 34,058 
(100.00)  
19,495 (57.24)  9,175 (26.94)  5,338 (15.82)  
Original cognitive tests at follow-up 
Numeric memory 
(Z score)  





10,573 (31.04)  




6,114 (31.36)  




2,718 (29.62)  





-0.38 (0.95)   
Pairs matching (Z 
score)  
n (%) missing  
Mean (SD)  
 
 
2,587 (7.60)  
0.25 (1.06)  
 
 
1,527 (7.83)  
0.24 (1.06)  
 
 
598 (6.52)  
0.27 (1.05)  
 
 
463 (8.57)  
0.24 (1.05)  
Prospective 
memory 
n (%) missing  
n (%) correct on 
first attempt  
 
 
2,065 (6.06)  




15,810 (77.87)  
 
 
473 (5.16)  
7,483 (81.56)  
 
 
367 (6.81)  
4,176 (77.51)  
Reaction time (Z 
score)  
n (%) missing 
Mean (SD)  
 
 
2,259 (6.63)  
0.04 (0.96)  
 
 
1,339 (6.87)  
0.05 (0.96)  
 
 
518 (5.65)  
0.03 (0.95)  
 
 
402 (7.46)  
-0.01 (0.97)  
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 Total sample  Active (≥10 
MET hours 
mvPA/week)   
Inactive (<10 
MET hours of 









2,638 (7.75)  
-0.20 (0.96)  
 
 
1,571 (8.06)  
- 0.22 (0.95)  
 
 
598 (6.52)  
- 0.10 (0.97)  
 
 
469 (8.70)  
-0.26 (0.98)  




n (%) missing 









6,417 (32.92)  




2,868 (31.26)  




1,833 (34.02)  
-0.25 (0.94)  
Paired associate 
learning (Z score)  
n (%) missing  
Mean (SD)  
 
 
11,581 (34.00)  
-0.22 (0.83)  
 
 
6,702 (34.38)  
-0.23 (0.83)  
 
 
2,994 (32.63)  
- 0.17 (0.81) 
 
 
1,885 (34.99)  









11,097 (32.58)  




6,410 (32.88)  




2,858 (31.15)  




1,829 (33.95)  














6,516 (33.42)  




2,927 (31.90)  




1,868 (34.67)  
-0.14 (0.96)  
Trails B-A, time (Z 
score)  




11,730 (34.44)  
0.03 (0.96)   
 
 
6,795 (34.86)  
0.00 (0.96)  
 
 
2,996 (32.65)  
0.08 (0.94)  
 
 
1,939 (35.99)  
0.03 (0.95)  
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 Total sample  Active (≥10 
MET hours 
mvPA/week)   
Inactive (<10 
MET hours of 
mvPA/week)   
Missing PA 
statusa 
Trails A, time (Z 
score)  




11,134 (32.69)  
0.04 (0.96)  
 
 
6,435 (33.01)  
0.02 (0.96)  
 
 
2,863 (31.20)  
0.08 (0.95)  
 
 
1,836 (34.08)  
0.05 (0.95)   
Trails B, time (Z 
score)  




11,730 (34.44)  
0.04 (0.96)  
 
 
6,795 (34.86)  
0.00 (0.96)  
 
 
2,996 (32.65)  
0.10 (0.95)  
 
 
1,939 (35.99)  
0.04 (0.95)  
Trails B, errors (Z 
score)  








6,493 (33.31)  
0.96 (1.57)  
 
 
2,885 (31.44)  
1.05 (1.55)  
 
 
1,852 (34.37)  
0.96 (1.57)  
Composite CF measures 
Global CF (Z 
score)b 
n (%) missing  
Mean (SD)  
 
 
2,370 (6.96)  
-0.05 (0.56)  
 
 
1,407 (7.22)  
-0.06 (0.57)   
 
 
539 (5.87)  
-0.10 (0.56)   
 
 
424 (7.87)  

















6,446 (33.06)  





2,879 (31.38)  





1,843 (34.21)  











11,186 (32.84)  





6,461 (33.14)  





2,875 (31.34)  





1,850 (34.34)  
-0.02 (0.72)   
80 
 
 Total sample  Active (≥10 
MET hours 
mvPA/week)   
Inactive (<10 
MET hours of 











11,281 (33.12)  




6,158 (33.43)  




2,905 (31.66)  




1,858 (34.48)  









10,410 (30.57)  




6,024 (30.90)  




2,681 (29.22)  




1,705 (31.64)  
-0.12 (0.62)  
 
Abbreviations: CF, cognitive function; MET, Metabolic Equivalent of Task; mvPA, moderate-vigorous PA; PA , physical activity; SD, Standard deviation 
Footnotes for table: 
a: Individuals were classified as active if they met ≥10 MET hours of moderate to vigorous PA per week. However, they also reported levels of light PA (walking) which did not contribute to 
this classification. Total PA includes light PA as well as mvPA. Therefore, there is a subset of individuals who are non-missing on light PA, but missing on both moderate and vigorous PA. These 
individuals will have a value for total PA but be counted as missing PA classification 
b: Global CF = mean of z scores on ten tests assuming at least two non-missing values 
c: Processing speed composite = mean of Digit Symbol Substitution and Reaction Time (assuming non-missing on both measures)  
d: Executive function composite = mean of Tower Rearranging, Trails A and Trails B completion time (assuming non-missing on two measures)  
e: Reasoning composite = mean of Reasoning test and Matrix Pattern Completion (assuming non-missing on both measures)  






Table 2: Cross-sectional regression models for baseline cognitive function   






















300,847 -.0005355 -.0006077, -.004634 <.0001 <.0001 29,664 -.0001841 -.0004921, .0001239 .2855 .5365 
Reasoning  100,204 -.0023377 -.0024488, -.0022266 <.0001 <.0001 12,438 -.0009303 -.001292, -.0005685 <.0001 <.0001 
Numeric 
Memory  
31,854 -.0012581 -.014492, -.0010669 <.0001 <.0001 3,613 -.0001427 -.0008524, .0005669 .6934 .6934 




89,022  .9981991 .9979159, .998482 <.0001 <.0001 2,548  .9986968 .9955481, 1.001856 .4183 .53652 
Abbreviations: CF, cognitive function; CI, confidence interval; FDR, False Discovery Rate;  MET, Metabolic Equivalent of Task; PA , physical activity; Uncorr, uncorrected 
a: All expressed as z scores, except Prospective Memory which is expressed as an odds ratio 
b: Adjusted for: alcohol binge, alcohol frequency, antihypertensive medication, apoe-e4 allele count, BMI, cardiovascular disease dx, dementia genetic risk score, diabetes dx, distance to 
major road, friend and family visits, gender, hdl cholesterol, head injury dx, household income, kidney disease dx, KJ of energy, ldl cholesterol, living alone status, manual work, mood disorder 
dx, musculoskeletal dx, neurological disorder dx, neuroticism score psychosis dx, psychotropic medication, salt added to food, smoking status, Townsend deprivation score, trauma status, 
waist circumference, worrier status. Also adjusted for technical covariates used with genetic risk scores  
c: Probability adjusted using the Simes-Benjamini-Hochberg method implemented in the Stata qqvalue package 





Table 3: Longitudinal regression models for follow-up cognitive function  























30,153 -.0000553 -.0002922, .0001816 .6474 .6474 6,816  .0001664 -.0004255, .0007584 .5816 .6394 
Pairs 
Matching 
29,845 -.000428 -.0006911, -.0001649 .0014 .0015 6,780 -.0001783 -.000858, .0005014 .6071 .6394 
Reasoning 29,801 -.0027912 -.0030282, -.0025542 <.0001 <.0001 6,779 -.0017126 -.0022898,-.001134 <.0001 <.0001 
Numeric 
Memory   
22,321 -.001635 -.0019111, -.0013588 <.0001 <.0001 5,006 -.0015375 -.0022407,-.0008344 .6394 .6394 
Symbol Digit 
Substitution  




21,343 -.0015357 -.0017798, -.0012917 <.0001 <.0001 4,805 -.0004867 -.0011079, .0001346 .1247 .1727 
Tower 
Rearranging 




21,804 -.0019887 -.0022625, -.001715 <.0001 <.0001 4,881 -.0009316 -.0016148, -.0002483 .0075 .0193 
Prospective 
Memory 
30,330  .9971918  
  
.9965854    .9977987 <.0001 <.0001 6,840  .9981081 .9961615, 1.000058 .0573 .0893 
Trails A (time)  21,709 -.0013174 -.0015988,- .0010359     <.0001 <.0001 4,874 -.0007286 -.0014642,.0000005 .0518 .0893 
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Trails B (time) 21,225 -.0019304 - .0022155,-.0016453    <.0001 <.0001 4,827 -.0010314 -.0017477, -.0003152 .0048 .0173 
Trails B-A 
(time) 
21,225 -.0015662 -.0018518,-.0012806     <.0001 <.0001 4,827 -.0009099 -.0016336, -.0001862 .0137 .0274 
Trails B 
(errors)  
21,698 -.002139 -.0026008, -.0016773     <.0001 <.0001 4,866 -.0015567 .-0027763, -.000337 .0124 .0274 
Processing 
Speed (comp)d 




21,742 -.001489 -.0017003 , -.0012777 <.0001 <.0001 4,871 -.0007267 -.0012586   -.0001947 .0074 .0193 
Reasoning 
(comp)f 
21,655 -.0024415 -.0026714, -.0022116 <.0001 <.0001 4,866 -.0013687 -.0019174, -.0008199 <.0001 <.0001 
Memory 
(comp)g 
22,467 -.0011893 -.0013674, -.0010112 <.0001 <.0001 5,029 -.0007394 -.0011853, -.0002936 .0012 .0054 
Global CF 
(comp)h 
30,048 -.0012926 -.0014324, -.0011529 <.0001 <.0001 6,804 -.0006555 -.0010004, -.0003107 .0002 .0012 
 
Exposure  















Reaction Time 14,307 .0029557 .0012409, .0046705 .0007 .0063 3,935 .002567 -.0007845, .0059099 .1334 .8058 
Pairs Matching 14,164 -.0009559 -.0028609, .0009492 .3254 .3584 3,919 .0006546 -.0046161, .0033069 .7460 .8952 
Reasoning 14,148 .0009323 -.0026586, .000794 .2898 .3478 3,919 .0001802 -.0035365, .0031761 .9162 .9162 
Numeric 
Memory  











9,522 .0015174 -.0003052, .0033401 .1027 .1849 2,731 -.0006999 -.0042253, .0028255 .6971 .8952 
Prospective 
Memory  
14,392 1.006038 1.0007, 1.011405 .0266 .0798 3,828 1.003531 .9898692, 1.017381 .6143 .8952 
Tower 
Rearranging 
9,611 -.0019001 -.0039706, .0001704 .0721 .1566 2,759 -.0028300 -.0070429, .0013830 .1879 .8058 
Matrix Pattern 
Completion  
9,670 -.0009633 -.0030134, .0010868 .3570 .3584 2,768 -.0009649 -.0051264, .0031966 .6494 .8952 
Trails A (time)  9,668 .0030946 .0010132, .005176 .0036 .0162 2,766 -.0010388 -.0052679, .0031902 .6301 .8952 
Trails B (time) 9,455 .0026019 .0004972, .0047067 .0154 .0554 2,742 -.0026095 -.0067544, .0015354 .2171 .8058 
Trails B-A 
(time) 
9,455 .0018798 -.0002126, .0039721,  .0783 .1566 2,742 -.0023665 -.006514, .0017809 .2633 .8058 
Trails B (errors)  9,362 .001587 -.001800, .004974  .3584 .3584 2,760 -.0051376 -.0117453, .0014702 .1275 .8058 
Processing 
Speed (comp)d 




9,650 .0001975 -.0029336, .0033287 .1309 .2142 2,764 .0001975 -.0029336, .0033287 .9016 .9162 
Reasoning 
(comp)f 
9,612 -.0010418 -.0027634, .0006798 .2356 .3228 2,763 .0016841 -.0051657, .0014390 .2686 .8058 
Memory 
(comp)g 
9,964 .0009278 -.0004027, .0022584 .1717 .2576 2,848 -.0006474 -.0032057, .0019109 .6198 .8952 
Global CF 
(comp)h 




Abbreviations: CF, cognitive function; CI, confidence interval; FDR, False Discovery Rate;  MET, Metabolic Equivalent of Task; PA , physical activity; Uncorr, uncorrected 
a: All expressed as z scores, except Prospective Memory which is expressed as an odds ratio 
b: Adjusted for: alcohol binge, alcohol frequency, antihypertensive medication, apoe-e4 allele count, BMI, cardiovascular disease dx, dementia genetic risk score, diabetes dx, distance to 
major road, friend and family visits, gender, hdl cholesterol, head injury dx, household income, kidney disease dx, KJ of energy, ldl cholesterol, living alone status, manual work, mood disorder 
dx, musculoskeletal dx, neurological disorder dx, neuroticism score psychosis dx, psychotropic medication, salt added to food, smoking status, Townsend deprivation score, trauma status, 
waist circumference, worrier status. Also adjusted for technical covariates used with genetic risk scores.  
c: Probability adjusted using the Simes-Benjamini-Hochberg method implemented in the Stata qqvalue package. 
d: Processing speed composite = mean of Digit Symbol Substitution and Reaction Time (assuming non-missing on both measures)  
e: Executive function composite = mean of Tower Rearranging, Trails A and Trails B completion time (assuming non-missing on two measures)  
f: Reasoning composite = mean of Reasoning test and Matrix Pattern Completion (assuming non-missing on both measures)  
g: Memory composite = mean of Pairs Matching, Numeric Memory and Paired Associate Learning (assuming non -missing on two measures)  




Main findings  
In this study using a large cohort of middle to early old age adults of white British ancestry to 
estimate the causal effect of PA on CF, there was virtually zero association between these 
variables. Due to very large sample sizes some of the effect estimates did reach thresholds for 
statistical significance; however, they were of trivially small magnitude, and became smaller 
after adjustment for covariates. Planned analyses of mediating pathways via structural brain 
differences were not conducted due to the inconsistency in the direction of the total effects 
estimates. This pattern of results was unexpected as it does not align with most of the recent 
literature reviewed in chapter one, although a minority of the reviewed studies also reported 
no association between PA and CF (Morgan et al., 2012; Sabia et al., 2017; Tan et al., 2017; 
Verghese, Wang, Katz, Sanders, & Lipton, 2009). In common with two of these studies, the UK 
Biobank sample was younger at baseline than most of the other cohorts in which protective 
effects have been found. Taken together, the present findings may support the suggestion 
that observed effects in older baseline samples reflect reverse causality, whereby some 
participants had preclinical cognitive decline at baseline, and lower PA was a symptom, rather 
than a cause, of changes in brain health. Indeed, a growing body of evidence demonstrates 
that earlier changes in behaviour predict later dementia diagnosis, before cognitive symptoms 
manifest (Bayat et al., 2021). Studies with younger samples at baseline reduce the risk that 
preclinical disease processes have begun. Other potential explanations for the present finding 
are considered below.  
Selection bias  
The UK Biobank sample is known not to be representative of the general population, with 
participants less likely to engage in unhealthy behaviours and experience negative health 
outcomes (Fry et al., 2017). When both exposure and outcome are related to participation in 
studies this can lead to collider bias (discussed in figure 1, chapter one), and it is plausible that 
both higher levels of PA and better cognitive health influence participation and retention 
within UK Biobank. Indeed, the sample who returned for imaging were more active, less 
deprived and healthier than the total sample. The implication is that the true relationship 
between PA and CF may be distorted within UK Biobank due to participants’ better health, as 
has been observed with other anticipated effects (Lyall et al., 2021).  
Model misspecification  
Another explanation may be model misspecification. In particular, the model in this thesis 
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represents PA (at the point it is measured in UK Biobank) as downstream of health outcomes 
such as cardiometabolic disease. As such, these were specified as confounders and adjusted 
for. However, one hypothesised mechanism by which PA may affect CF is by reducing 
cardiometabolic risk, meaning the adjusted models in this the present study would have 
removing part of the effect of interest by over-adjustment (Schisterman, Cole, & Platt, 2009). 
However, given that the unadjusted effect sizes were also trivially small it is unlikely that over-
adjustment accounts for the observed findings. There were also three confounders specified 
by the model that were not adjusted for due to lack of matches within the available data 
(childhood PA, earlier adulthood PA and childhood IQ). Whilst their omission represents 
residual bias within the model, it remains unlikely that including these would have made a 
substantial difference to the pattern of results.  
Age of sample  
It may also be the case that the benefits of PA on CF would not be observable until later in life 
when a greater degree of cognitive decline would be expected (Salthouse, 2009). Indeed, in 
much of the literature reviewed in chapter one which found a protective effect of PA on CF, 
the samples were into the eighth and ninth decades of life at follow-up, whereas the present 
sample at follow-up were in their seventh decade of life. It remains possible that the 
protective effect of PA is yet to be realised within this relatively young cohort.  
Strengths and limitations  
There are several features of this study that represent both a strength and a weakness. The 
application of a causal inference framework to examine the effect of PA on CF represents a 
novel contribution to the literature, and the construction of the DAG was done to a standard 
of rigour and transparency that is not common within existing literature (Tennant et al., 2019). 
However, the complexities of the model posed practical limitations such as being unable to 
interrogate it comprehensively using the available software, meaning that the plausible 
variations of the specified model were not explored. Nor were the implied independencies of 
the model tested against the measured data, which is another way of assessing model fit 
(Textor, Hardt, & Knüppel, 2011).  
The use of UK Biobank data also represents a trade-off in terms of strengths and limitations. 
The range and detail of measures available within this resource allowed a close approximation 
of the complex conceptual model to be estimated statistically, including genomic, 
environmental and lifestyle covariates. However, the internal and external validity of the 
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findings is limited due to the selection bias within the sample, and the genetic ancestry 
stratification means results cannot be generalised beyond populations of white British 
ancestry. A sensitivity analysis was performed to examine the effect of missing data, however 
further analyses involving multiple imputation of missing values were not conducted.  
Finally, the measurement of exposure and outcome were strengths of the present study. 
Cognitive data was utilised to represent the various conceptualisations of CF within the 
literature. Previous studies have tended to examine either individual test scores, domain-level 
averages, or total-scores across domains (global CF), whereas the present study considered all 
these variations. This study also benefited from having both self-report and objective 
measures of PA.  
Implications and future directions  
Due to limitations to both internal and external validity discussed above, the present results 
should be interpreted with caution. However, in the context of existing literature, the finding 
of no meaningful association between PA and CF aligns with other studies that had younger 
baseline samples and may lend weight to the reverse causation hypothesis. Alternatively, the 
null findings may reflect the suppression of true effects due to collider bias induced by the 
factors influencing participation and retention within the UK Biobank sample. Future research 
using UK Biobank can explore whether the hypothesised protective effect of PA on CF does 
emerge as the cohort matures. 
Conclusions  
This study estimated the causal effect of PA on CF based on a comprehensive model derived 
within a causal inference framework, using a very large sample of middle to early old-aged UK 
adults of white British ancestry. The expected protective effect was not observed. This may 
reflects selection bias within UK Biobank, or the relatively young age of the sample at follow-
up. However, it is also possible that previous studies with older samples have over-estimated 
the association of PA and CF due to reverse causation. Future research could utilise the 
conceptual model advanced in this thesis to examine whether effects of PA on CF emerge as 
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Appendix 1.1: Journal of Neuropsychology submission guidelines* 
* Including scope and manuscript requirements. For full guidance see link below:  
https://bpspsychub.onlinelibrary.wiley.com/hub/journal/17486653/homepage/forauthors.ht
ml )  
JNP AUTHOR GUIDELINES 
Sections 
1. SUBMISSION 
Authors should kindly note that submission implies that the content has not been 
published or submitted for publication elsewhere except as a brief abstract in the 
proceedings of a scientific meeting or symposium. 
Once the submission materials have been prepared in accordance with the 
Author Guidelines, manuscripts should be submitted online 
at http://www.editorialmanager.com/jnp 
Click here for more details on how to use Editorial Manager. 
All papers published in the Journal of Neuropsychology are eligible for Panel A: 
Psychology, Psychiatry and Neuroscience in the Research Excellence Framework (REF). 
Data protection: 
By submitting a manuscript to or reviewing for this publication, your name, email 
address, and affiliation, and other contact details the publication might require, will be 
used for the regular operations of the publication, including, when necessary, sharing 
with the publisher (Wiley) and partners for production and publication. The 
publication and the publisher recognize the importance of protecting the personal 
information collected from users in the operation of these services, and have practices 
in place to ensure that steps are taken to maintain the security, integrity, and privacy 
of the personal data collected and processed. You can learn more 
at https://authorservices.wiley.com/statements/data-protection-policy.html. 
Preprint policy: 
This journal will consider for review articles previously available as preprints. Authors 
may also post the submitted version of a manuscript to a preprint server at any time. 
Authors are requested to update any pre-publication versions with a link to the final 
published article.  
2. AIMS AND SCOPE 
The Journal of Neuropsychology publishes original contributions to scientific 
knowledge in neuropsychology including: 
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• clinical and research studies with neurological, psychiatric and psychological 
patient populations in all age groups 
• behavioural or pharmacological treatment regimes 
• cognitive experimentation and neuroimaging 
• multidisciplinary approach embracing areas such as developmental 
psychology, neurology, psychiatry, physiology, endocrinology, pharmacology 
and imaging science 
The following types of paper are invited: 
• papers reporting original empirical investigations 
• theoretical papers; provided that these are sufficiently related to empirical 
data 
• review articles, which need not be exhaustive, but which should give an 
interpretation of the state of research in a given field and, where appropriate, 
identify its clinical implications 
• brief reports and comments 
• case reports 
• fast-track papers (included in the issue following acceptation) reaction and 
rebuttals (short reactions to publications in JNP followed by an invited rebuttal 
of the original authors) 
• special issues. 
3. MANUSCRIPT CATEGORIES AND REQUIREMENTS 
• Research papers should be no more than 6000 words (excluding the abstract, 
reference list, tables and figures). Multiple citations for a single point are 
usually duplicative and authors are urged to cite the best reference. In 
exceptional cases the Editor retains discretion to publish papers beyond this 
length where the clear and concise expression of the scientific content requires 
greater length (e.g., explanation of a new theory or a substantially new 
method). Authors must contact the Editor prior to submission in such a case. 
• Brief communications are short reports of original research or case reports. 
They are limited to a maximum of 1500 words (excluding the abstract, 
reference list, tables and figures) and have a total of up to three tables or 
figures, and no more than 10 references. 
• Theoretical or review articles are full-length reviews of, or opinion statements 
regarding, the literature in a specific scientific area. They should be no more 
than 4000 words (excluding the abstract, reference list, tables and figures) and 
have no more than 45 references. Multiple citations for a single point are 
usually duplicative and authors are urged to cite the best reference. In 
exceptional cases the Editor retains discretion to publish papers beyond this 
length where the clear and concise expression of the scientific content requires 
greater length (e.g., explanation of a new theory or a substantially new 
method). Authors must contact the Editor prior to submission in such a case. 
• Please refer to the separate guidelines for Registered Reports. 
• All systematic reviews must be pre-registered. 
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4. PREPARING THE SUBMISSION 
Free Format Submission 
Journal of Neuropsychology now offers free format submission for a simplified and 
streamlined submission process. 
Before you submit, you will need: 
• Your manuscript: this can be a single file including text, figures, and tables, or 
separate files – whichever you prefer. All required sections should be 
contained in your manuscript, including abstract, introduction, methods, 
results, and conclusions. Figures and tables should have legends. References 
may be submitted in any style or format, as long as it is consistent throughout 
the manuscript. If the manuscript, figures or tables are difficult for you to read, 
they will also be difficult for the editors and reviewers. If your manuscript is 
difficult to read, the editorial office may send it back to you for revision. 
• The title page of the manuscript, including a data availability statement and 
your co-author details with affiliations. (Why is this important? We need to keep 
all co-authors informed of the outcome of the peer review process.) You may like to 
use this template for your title page. 
Important: the journal operates a double-blind peer review policy. Please 
anonymise your manuscript and prepare a separate title page containing author 
details. (Why is this important? We need to uphold rigorous ethical standards for the 
research we consider for publication.) 
• An ORCID ID, freely available at https://orcid.org. (Why is this important? Your 
article, if accepted and published, will be attached to your ORCID profile. 
Institutions and funders are increasingly requiring authors to have ORCID IDs.) 
To submit, login at https://www.editorialmanager.com/jnp/default.aspx and 
create a new submission. Follow the submission steps as required and submit the 
manuscript. 
If you are invited to revise your manuscript after peer review, the journal will also 
request the revised manuscript to be formatted according to journal requirements as 
described below. 
Revised Manuscript Submission 
Contributions must be typed in double spacing. All sheets must be numbered. 
Cover letters are not mandatory; however, they may be supplied at the author’s 
discretion. They should be pasted into the ‘Comments’ box in Editorial Manager. 
Parts of the Manuscript 
The manuscript should be submitted in separate files: title page; main text file; 
figures/tables; supporting information. 
Title Page 
You may like to use this template for your title page. The title page should contain: 
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• A short informative title containing the major key words. The title should not 
contain abbreviations (see Wiley's best practice SEO tips); 
• A short running title of less than 40 characters; 
• The full names of the authors; 
• The author's institutional affiliations where the work was conducted, with a 




• Data availability statement (see Data Sharing and Data Accessibility Policy); 
• Acknowledgments. 
Authorship 
Please refer to the journal’s Authorship policy in the Editorial Policies and Ethical 
Considerations section for details on author listing eligibility. When entering the 
author names into Editorial Manager, the corresponding author will be asked to 
provide a CRediT contributor role to classify the role that each author played in 
creating the manuscript. Please see the Project CRediT website for a list of roles. 
Abstract 
Please provide an abstract which gives a concise statement of the intention, results or 
conclusions of the article. The abstract should not include any sub-headings. 
• Abstracts for Research Papers should not exceed 250 words. 
• Abstracts for theoretical or review articles should not exceed 250 words. 
• Abstracts for brief communications should not exceed 80 words. 
Keywords 
Please provide appropriate keywords. 
Acknowledgments 
Contributions from anyone who does not meet the criteria for authorship should be 
listed, with permission from the contributor, in an Acknowledgments section. Financial 
and material support should also be mentioned. Thanks to anonymous reviewers are 
not appropriate. 
Main Text File 
As papers are double-blind peer reviewed, the main text file should not include any 
information that might identify the authors. 
The main text file should be presented in the following order: 
• Title 
• Main text 
• References 
• Tables and figures (each complete with title and footnotes) 
• Appendices (if relevant) 
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Supporting information should be supplied as separate files. Tables and figures can be 
included at the end of the main document or attached as separate files but they must 
be mentioned in the text. 
• As papers are double-blind peer reviewed, the main text file should not include 
any information that might identify the authors. Please do not mention the 
authors’ names or affiliations and always refer to any previous work in the 
third person. 
• The journal uses British/US spelling; however, authors may submit using either 
option, as spelling of accepted papers is converted during the production 
process. 
References 
References in published papers are formatted according to the Publication Manual of 
the American Psychological Association (6th edition). However, references may be 
submitted in any style or format, as long as it is consistent throughout the 
manuscript.  
Tables 
Tables should be self-contained and complement, not duplicate, information 
contained in the text. They should be supplied as editable files, not pasted as images. 
Legends should be concise but comprehensive – the table, legend, and footnotes must 
be understandable without reference to the text. All abbreviations must be defined in 
footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** 
should be reserved for P-values. Statistical measures such as SD or SEM should be 
identified in the headings. 
Figures 
Although authors are encouraged to send the highest-quality figures possible, for 
peer-review purposes, a wide variety of formats, sizes, and resolutions are accepted. 
Click here for the basic figure requirements for figures submitted with manuscripts 
for initial peer review, as well as the more detailed post-acceptance figure 
requirements. 
Legends should be concise but comprehensive – the figure and its legend must be 
understandable without reference to the text. Include definitions of any symbols used 
and define/explain all abbreviations and units of measurement. 
Colour figures. At the editors' discretion, colour figures can be provided for use in the 
journal. Good quality photographs will be considered where they add substantially to 
the argument, to a maximum of three per article. These can be supplied electronically 
as TIF files scanned to at least 300dpi. If they are printed in colour, then they can be 
reproduced in colour online and black and white in print. 
Supporting Information 
Supporting information is information that is not essential to the article, but provides 
greater depth and background. It is hosted online and appears without editing or 
typesetting. It may include tables, figures, videos, datasets, etc. 
Click here for Wiley’s FAQs on supporting information. 
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Note: if data, scripts, or other artefacts used to generate the analyses presented in the 
paper are available via a publicly available data repository, authors should include a 
reference to the location of the material within their paper. 
General Style Points 
For guidelines on editorial style, please consult the APA Publication 
Manual published by the American Psychological Association. The following points 
provide general advice on formatting and style. 
• Language: Authors must avoid the use of sexist or any other discriminatory 
language. 
• Abbreviations: In general, terms should not be abbreviated unless they are 
used repeatedly and the abbreviation is helpful to the reader. Initially, use the 
word in full, followed by the abbreviation in parentheses. Thereafter use the 
abbreviation only. 
• Units of measurement: Measurements should be given in SI or SI-derived 
units. Visit the Bureau International des Poids et Mesures (BIPM) website for 
more information about SI units. 
• Effect size: In normal circumstances, effect size should be incorporated. 
• Numbers: numbers under 10 are spelt out, except for: measurements with a 
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Paper Embase Medline Psychinfo Overall 
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Chang, M., Jonsson, P.V., Snaedal, J., Bjornsson, S., 
Saczynski, J.S., Aspelund, T.,...Launer, L.J. (2010) . 
The effect of midlife physical activity on cognitive 
function among older adults: AGES—Reykjavik Study. 
Jour- nals of Gerontology. Series A, Biological Sci- 
ences and Medical Sciences, 65, 1369-1374. 
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de Bruijn, R.F., Schrijvers, E.M., de Groot, K.A., 
Witteman, J.C., Hofman, A., Franco, O.H.,...Ikram, 
M.A. (2013). The association between physical activity 
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Study. European Journal of Epide- miology, 28, 277-283. 
doi:10.1007/s10654- 013-9773-3
y y n y
Luck, T., Riedel-Heller, S.G., Luppa, M., Wiese, B., 
Kohler, M., Jessen, F.,...Maier, W. (2014). 
Apolipoprotein E epsilon 4 genotype and a physically 
active lifestyle in late life: Analysis of gene-environment 
interaction for the risk of dementia and Alzheimer’s 
disease dementia. Psychologi- cal Medicine, 44, 1319-
1329. doi:10.1017/ S0033291713001918 
y y y y
Heser, K., Wagner, M., Wiese, B., Prokein, J., Ernst, 
A., Konig, H.H.,...Eisele, M. (2014). Associations 
between dementia outcomes and depressive symptoms, 
leisure activities, and social support. Dementia and 
Geriat- ric Cognitive Disorders Extra, 4, 481-493. 
doi:10.1159/000368189
n y n y
Podewils, L.J., Guallar, E., Kuller, L.H., Fried, L.P., 
Lopez, O.L., Carlson, M., & Lyketsos, C.G. (2005). 
Physical activity, APOE genotype, and dementia risk: 
Findings from the Cardiovascular Health Cognition 
y y n y
Rovio, S., Kareholt, I., Helkala, E.L., Viitanen, M., 
Winblad, B., Tuomilehto, J.,... Kivipelto, M. (2005) . 
Leisuretime physi- cal activity at midlife and the risk of 
de- mentia and Alzheimer’s disease. Lancet Neurology, 
y y n y
Sabia, S., Dugravot, A., Dartigues, J.F., Abell, J., 
Elbaz, A., Kivimaki, M., & Singh-Manoux, A. (2017). 
Physical activity, cognitive decline, and risk of 
dementia: 28 year follow- up of Whitehall II cohort 
study. BMJ, 357, j2709. doi:10.1136/bmj.j2709
y y y y
Tolppanen, A.M., Solomon, A., Kulmala, J., 
Kareholt, I., Ngandu, T., Rusanen, M.,... Kivipelto, 
M. (2015). Leisure-time physi- cal activity from mid- to 
late life, body mass index, and risk of dementia. 
Alzheimer’s & Dementia, 11, 434-443. doi:10.1016/j. 
jalz.2014.01.008
y y y y
Baezner, H., Blahak, C., Poggesi, A.,... Inzitari, D. 
(2012). Physical activity prevents progression for 
cognitive impairment and vascular dementia: Results 
from the LADIS (Leukoaraiosis and Disability) study. 
Stroke, 43, 3331-3335. doi:10.1161/ 
STROKEAHA.112.661793 
y y n y
Fenesi, B., Fang, H., Kovacevic, A., Oremus, M., Raina, P., & 
Heisz, J.J. (2017). Physical exercise moderates the 
relationship of apolipoprotein E (APOE) genotype and 
dementia risk: A population-based study. Journal of 
Alzheimer’s Disease, 56, 297-303. doi:10.3233/JAD-160424 
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Appendix 1.4: Screening eligibility checklist*  
*Amendments made between versions 1 and 2 are shown in stage 3 (full-text) section 
in bold red text. 
Systematic Review Article Screening Tool (v2) 
Developed using:  
- Polanin, J. R., Pigott, T. D., Espelage, D. L., & Grotpeter, J. K. (2019). Best practice 
guidelines for Abstract screening large‐evidence systematic reviews and meta‐
analyses. Research Synthesis Methods, 10(3), 330-342. 
Stage 1: Citation, title and abstract screening  
Citation, Title, and Abstract Screening 
1. Does the citation indicate publication on or after 2005? 
a. Yes: continue screening 
b. No: stop screening  
2. Does the title or abstract use English? 
a. Yes: continue screening 
b. No: stop screening  
3. Does the title or abstract indicate that this is NOT a review paper (systematic 
review/meta-analysis) or an intervention study, e.g. an RCT.  
a. Yes: continue screening 
b. No: stop screening  
4. Does the title or abstract indicate that study population is NOT children/adolescents  
a. Yes: continue screening 
b. No: stop screening  
5) Does the title or abstract indicate that the participants were free of cognitive 
impairment at baseline?  
a. Yes: continue screening 
b. No: stop screening  
- For example, the title or abstract indicates that participants had dementia 
diagnosis or MCI at baseline  
 
Stage 2: Abstract screening  
6. Does the abstract indicate that the age of the sample was  ≥45 - <80  at baseline? 
a. Yes or unsure/unclear: continue screening 
b. No: stop screening  
- For example if abstract indicated that entire sample were <45, or >80 at 
baseline, or that the mean age of the sample at baseline was out with ≥45 -<80  at 
baseline  
7. Does the abstract indicate that this study was longitudinal in design?  
 a. Yes or unsure/unclear: continue screening 
- Key words: prospective, cohort study, follow-up, multiple time-points, 
waves  
b. No: stop screening  
- For example study described as cross-sectional, retrospective, or as an 
RCT or other type of intervention study  
8. Does the abstract indicate that physical activity was studied as primary exposure of 
interest?  
a. Yes or unsure/unclear: continue screening 
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- Key words: physical activity, exercise, fitness, accelerometer, walking. If the paper 
mentions PA as a ‘joint’ primary exposure, e.g. ‘Cognitive and physical activity’, 
include the paper. 
b. No: stop screening 
- For example, if PA is not included at all, or if PA is mentioned only as a covariate; 
or if the paper is looking more generally at range of predictors of cognitive function 
 
9. Does the abstract indicate that cognitive function/decline, including dementia or 
Alzheimer’s diagnosis, using neuropsychological test(s) was measured?  
a. Yes or unsure/unclear: continue screening 
b. No: stop screening 
- For example, if the outcome is Dementia/Alzheimer diagnosis according to 
linked health records (diagnosis), but without any report of 
neuropsychological tests.  
 
Decision: Should this article be included for full-test screening? 
a. Yes, all X screening questions answered Yes or Unclear 
b. No, at least one answers definitely “No” 
 
Stage 3: Full-text screening:  
All of the criteria above still apply. Although they should have been assessed at the ti/ab 
stage is is worth re-checking the key info such as participant age range and study design. 
Inclusion Criteria: 
Design of study:  
Include if:  
Longitudinal design (exclude cross-sectional).  
If you are unsure then a quick way can be to search within the document for ‘longitudinal’ 
or ‘cross-sectional’.  
Exclude if:  
Any other type of design, e.g. intervention or retrospective.  
Cognitive function: 
Include if:  
-  Measured by use of objective tests (i.e. neuropsychological 
measures) including screening measures such as the MMSE and 
phone interview measures such as the TICS.  
- The study describes a process whereby an outcome (e.g. 
dementia) is determined by the use of a screening measure 
followed by clinical assessment – e.g. “further assessment 
subject to DSM diagnostic criteria”,   
Exclude if:  
- If the measures is subjective: i.e. subjective memory complaint, 
or subjective questions about change in cognition 
- If study only reports dementia diagnosis, without reference to 
cognitive measures (e.g. linked to insurance records or based 
on clinical interview only)  
Physical activity (many studies look at a range of predictors without any clear focus on 
PA) 
Include if:  
- Measured either objectively (accelerometer), or using self-
report questionnaires (either validated measures or simple 
questions about activity levels)  
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- PA is the main exposure or, or one of two exposures (e.g. 
looking at cognitive activity and PA, but not a whole range of 
exposures)  
- PA is the main exposure of interest and not merely included 
as a range of predictors of CF 
- If PA is one of two main exposures (e.g. PA & cognitive 
activity, or PA & APOE-e4). But not more than two.  
Exclude if:  
- There is no measure of physical activity  































































strategies   
(Barha et a l ., 2020)
(Etgen et a l ., 2010)
(Fiocco et a l ., 2012)
(Gow et a l ., 2017)
(Hal loway et a l ., 2017)
(Hamer et a l ., 2018)
(Iso-Markku et a l ., 2016)
(Larson et a l ., 2006)
(Morgan et a l ., 2012) 
(Ogino et a l ., 2019)
(Papenberg et a l ., 2016)
(Podewi ls  et a l ., 2005)
(Rabin et a l ., 2019) 
(Rajan et a l ., 2015)
(Reas  et a l ., 2019)
(Rovio et a l ., 2005)
(Sabia  et a l ., 2017)
(Tan et a l ., 2017)
(Thibeau et a l ., 2016)
(Verghese et a l ., 2009)
(Wi l ley et a l ., 2016)
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Appendix 1.6: Risk of bias/quality ratings  
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Appendix 2.4: Matching concepts to UK Biobank data process 
Concept Biobank match Link 
Acculturation Year moved to UK https://biobank.ndph.ox.ac.uk/showcase/field.cgi?id=3659 






Traumatic events https://biobank.ndph.ox.ac.uk/showcase/label.cgi?id=145 







First occurrences (pre 
baseline)  
https://biobank.ndph.ox.ac.uk/showcase/label.cgi?id=1712 
Brain health Grey matter normalized 
White matter grade  
(tract integrity) DTI 
Hippocampus volume 
Volume of anterior 
cingulate cortex  
Volume of dlPFC 
(represented by 

















Calcium  Blood biochemistry  https://biobank.ctsu.ox.ac.uk/crystal/field.cgi?id=30680  
Cardiovasular 
risk  
Atrial fibrillation  
 









Childhood IQ  Vocab measure from 
imaging visit  
 
Childhood PA  Not measured   








Baseline and follow up  https://biobank.ndph.ox.ac.uk/showcase/label.cgi?id=100026 
https://biobank.ndph.ox.ac.uk/showcase/label.cgi?id=116   
Diet     
Education  Degree or not  Derived dichotomous variable representing whether participant has college 
degree or not.  
Ethnicity  Ethnic category  https://biobank.ndph.ox.ac.uk/showcase/field.cgi?id=21000  
Family HX 
dementia/PD  
Parent or sibling with 
diagnosis  
 
Genetic risk  Dementia risk  Derived variables: described at  https://choishingwan.github.io/PRS-
Tutorial/ldpred/  
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596916/  
Inflammation  C-reactive protein  https://biobank.ndph.ox.ac.uk/showcase/field.cgi?id=30710  
Living alone  Number in household  https://biobank.ctsu.ox.ac.uk/crystal/field.cgi?id=709  
Manual work  Job involves manual 




Marital status  How are people in 








Physical activity  Baseline (self-report) 
MET scores  
 





Pollution  Inverse distance to 























Sex Sex baseline   https://biobank.ndph.ox.ac.uk/showcase/field.cgi?id=31  
Smoking status Tobacco history  https://biobank.ctsu.ox.ac.uk/crystal/field.cgi?id=24012  
Social network  Frequency of 
friend/family visits  
https://biobank.ctsu.ox.ac.uk/crystal/field.cgi?id=1031  
Sodium  Salt added to food  https://biobank.ctsu.ox.ac.uk/crystal/field.cgi?id=1478  
Trait anxiety  Neuroticism score  




Appendix 2.5: Description of covariate measures within UK Biobank 
Genetic  
A polygenic risk score for a combination of dementia genes was standardised as a z-score 
and treated as a continuous variable. A variable reflecting APOE genotype (number of e4 
alleles) was treated as continuous. Technical covariates related to genetic variables were 
also included in adjusted models.  
Sociodemographic variables 
Age was calculated by subtracting date of birth from assessment date. Acculturation was 
derived by subtracting date years in UK from date of birth. Gender, ethnic group and 
country of origin were self-reported via touchscreen interview. Townsend deprivation 
indices were derived from postcode of residence (categorised into quintiles with one 
representing the least, and five the most, deprived). Income was treated as an ordinal 
variable reflecting which category (low to high) participants belonged to. Education was 
dichotomised to reflect whether participant had a university/college degree or not. A 
variable representing exposure to pollution was derived using the inverse distance from a 
person’s home address to a major road and split into quintiles with one representing the 
farthest distance and five the nearest. Living alone was recorded by touch-screen interview 
and treated as dichotomous (yes/no).  
Health behaviours, medical risk factors and physical measurements 
Past and current smoking habits were self-reported via touch-screen interview and a binary 
variable (ever a smoker) was derived. Sodium intake and alcohol frequency were also self-
reported and treated as ordinal variables. Frequency of binge drinking (defined as greater 
than 6 units in one sitting) was recorded later using the web-questionnaire treated as an 
ordinal variable. A range of key biochemistry markers including and were measured using 
blood tests. Cholesterol (hdl, ldl and total) and calcium are treated as continuous variables 
expressed in mmol/L, and inflammation (serum C-reactive protein level, expressed in mg/L) 
is treated as ordinal. BMI was calculated by kg/m2 and treated as a continuous variable, and 
waist circumference was measured in cm and treated as continuous. Systolic and diastolic 
blood pressure were measured, expressed in mmHG, and treated as continuous variables.  
Medical comorbidities and medications 
Relevant medical diagnoses indicated by the conceptual model were all recorded using 
linked health records according to ICD-11 codes. Dichotomous variables whereby ‘yes’ 
represented the participant receiving a diagnosis on or before the date of baseline 
assessment. The relevant diagnostic categories were: neurological conditions, dementia, 
diabetes, chronic kidney disease, head injury, cerebrovascular disease, chronic lung disease, 
musculoskeletal conditions, mood disorder, psychotic illness and cardiovascular disease. 
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Dichotomous variables for antihypertensive and psychotropic medications were derived, 
coded ‘yes’ if the participant self-reported being on any medication within these categories.  
Mental health variables  
Trait anxiety was represented by a question asked at baseline (“are you a worrier?”) and 
treated as a dichotomous variable (yes/no). Neuroticism was measured using 12 self-report 
questions at baseline (e.g., “Are you an irritable person?) and a continuous variable was 
derived representing the number of items the participant answered yes to. Experience of 
trauma/adverse experiences was measured using the web-based questionnaire (e.g., “When 
I was growing up, someone sexually molested me”, and a dichotomous variable 
representing any incidence of trauma was derived. Mood was measured using four 
questions regarding depression symptoms, which were summed and treated as a 
continuous variable.  
Other  
Follow-up duration was calculated by subtracting the date of follow-up assessment from the 
date of baseline assessment and expressed in years.  
Covariates included in adjusted models:  
Alcohol binge, alcohol frequency, antihypertensive medication, apoe-e4 allele count, BMI, 
cardiovascular disease dx, dementia genetic risk score, diabetes dx, distance to major road, 
friend and family visits, follow-up time, gender, hdl cholesterol, head injury dx, household 
income, kidney disease dx, KJ of energy, ldl cholesterol, living alone status, manual work, 
mood disorder dx, musculoskeletal dx, neurological disorder dx, neuroticism score, 
psychosis dx, psychotropic medication, salt added to food, smoking status, technical genetic 
covariates, Townsend deprivation score, trauma status, waist circumference, worrier status. 






Appendix 2.6: Sensitivity analysis results table   
Cross sectional models  













n Estimate 95% CI p 
(uncorr) 
p (FDR) 
Reaction Time 305,294 .000131 .0000659, .0001962 .0001 <.0001 29,810 .0001306 -.0001092    .0003704 .2857 .3429 
Pairs Matching 
 
300,847 -.0005355 -.0006077, -.004634 <.0001 <.0001 29,664 -.0004247 -.0006967   -.0001528 .0022 .0033 
Reasoning  100,204 -.0023377 -.0024488, -.0022266 <.0001 <.0001 12,438 -.002656   -.002994   -.0023179 <.0001 <.0001 
Numeric 
Memory  
31,854 -.0012581 -.014492, -.0010669 <.0001 <.0001 3,613 -.0013487 -.001991   -.0007064 <.0001 <.0001 
Global CF  300,915 -.0004846 -.0005331,-.0004362 <.0001 <.0001 29,695 -.0005834 -.0007574   -.0004093 <.0001 <.0001 
Prospective 
Memory 
89,022  .9981991 .9979159, .998482 <.0001 <.0001 2,548  .9986968 .9955481, 1.001856 .4183 .4183 
Abbreviations: CF, cognitive function; CI, confidence interval; FDR, False Discovery Rate;  MET, Metabolic Equivalent of Task; PA , physical activity; Uncorr, uncorrected 
a: All expressed as z scores, except Prospective Memory which is expressed as an odds ratio 
b: Adjusted for: alcohol binge, alcohol frequency, antihypertensive medication, apoe-e4 allele count, BMI, cardiovascular disease dx, dementia genetic risk score, diabetes dx, distance to 
major road, friend and family visits, gender, hdl cholesterol, head injury dx, household income, kidney disease dx, KJ of energy, ldl cholesterol, living alone status, manual work, mood disorder 
dx, musculoskeletal dx, neurological disorder dx, neuroticism score psychosis dx, psychotropic medication, salt added to food, smoking status, Townsend deprivation score, trauma status, 
waist circumference, worrier status. Also adjusted for technical covariates used with genetic risk scores.  
c: Probability adjusted using the Simes-Benjamini-Hochberg method implemented in the Stata qqvalue package. 






Longitudinal models   

















Reaction time 30,153 -.0000553 -.0002922, .0001816 .6474 .6474 6,816  .0000752 -.0006065, .0004562 .7816 .7816 
Pairs matching 29,845 -.000428 -.0006911, -.0001649 .0014 .0015 6,780 -.0003613 -.0009561, .0002335 .2338 .2476 
Prospective 
Memory (  
30,330  .9971918  
  
.9965854    .9977987 <.0001 <.0001 6,840  . 9971716 .9955542, .9987915 .0006 .0007 
Reasoning 29,801 -.0027912 -.0030282, -.0025542 <.0001 <.0001 6,779 -.0032087 -.0037301, -.0026873  <.0001 <.0001 
Numeric 
Memory   
22,321 -.001635 -.0019111, -.0013588 <.0001 <.0001 5,006 -.0021687 -.0028092, -.0015282 <.0001 <.0001 
Symbol Digit 
Substitution  




21,343 -.0015357 -.0017798, -.0012917 <.0001 <.0001 4,805 -.0014098 -.0019326, -.0008871 <.0001 <.0001 
Tower 
Rearranging 
21,626 -.0011721 -.0014512, -.0008931 <.0001 <.0001 4,865 -.001141  -.0017697, -.0005123 .0004 .0005 
Matrix pattern 
completion  
21,804 -.0019887 -.0022625, -.001715 <.0001 <.0001 4,881 -.0021046 -.0027152, -.0014941 <.0001 <.0001 
Trails A (time)  21,709 -.0013174 -.0015988, -.0010359  <.0001 <.0001 4,874 -.0015953 -.0022335, -.0009571  <.0001 <.0001 
Trails B (time) 21,225 - .0019304 -.0022155, -.0016453 <.0001 <.0001 4,827 - .0023499 -.0029889, -.0017108  <.0001 <.0001 
Trails B – A 
(time)  
21,225 -.0015662 -.0018518, -.0012806  <.0001 <.0001 4,827 -.0019600 -.002588, -.0013319  <.0001 <.0001 





21,767 -.0009248 -.0011378, -.0007117 <.0001 <.0001 4,873 -.000999 -.0014791, -.000519 <.0001 <.0001 
Executive 
Function (comp) 
21,742 -.001489 -.0017003, -.0012777 <.0001 <.0001 4,871 -.0016902 -.002165, -.0012153 <.0001 <.0001 
Reasoning 
(comp) 
21,655 -.0024415 -.0026714, -.0022116 <.0001 <.0001 4,866 -.002725 -.0032274, -.0022226 <.0001 <.0001 
Memory (comp)  22,467 -.0011893 -.0013674, -.0010112 <.0001 <.0001 5,029 -.0012647 -.0016617, -.0008677 <.0001 <.0001 
Global CF 
(comp) 























Reaction time 14,307 .0029557 .0012409, .0046705 .0007 .0063 3,935 .0027609 -.0004749, .0059968 .1334 .8058 
Pairs matching 14,164 -.0009559 -.0028609, .0009492 .3254 .3584 3,919 -.0013041 -.0049577, .0023496 .7460 .8393 
Prospective 
Memory  
14,392  1.006038 1.0007, 1.011405 .0266 .0798 3,828  1.001839 .9904113, 1.013399 .9162 .9162 
Reasoning  14,148 .0009323 -.0026586, .000794 .2898 .3478 3,919 -.000163 -.0033863, .0030603 .8516 .9017 
Numeric 
Memory  
9,901 .0019117 -.0001713, .0039947 .0720 .1566 2,837 .0019519 -.0020293, .0059331 .3824 .8393 
Symbol Digit 
Substitution  









9,611 -.0019001 -.0039706, .0001704 .0721 .1566 2,759 -.0048043 -.0087284, -.0008802 .1879 .8058 
Matrix pattern 
completion  
9,670 -.0009633 -.0030134, .0010868 .3570 .3584 2,768 -.0012759   -.0051684, .0026166 .6494 .8393 
Trails A (time)  9,668 .0030946  .0010132, .005176 .0036 .0162 2,766 .0008261 -.0031038, .004756 .6301 .8393 
Trails B (time) 9,455 .0026019 .0004972, .0047067  .0154 .0554 2,742 .0023579 -.0016326, .0063484  .2171 .8058 
Trails B – A 
(time) 
9,455 .0018798 -.0002126, .0039721 .0783 .1566 2,742 .0022594 -.0016632, .0061819  .2633 .8058 
Trails B (errors)  9,362 .001587 -.001800, .004974  .3584 .3584 2,760 .0037901   -.0025624, .0101426 .1275 .8058 
Processing 
Speed (comp) 
9,653 .0035774 .0019994, .0051555 <.0001 .0002 2,763 .0014516 -.0014919, .0043952 .7386 .8393 
Executive 
Function (comp) 
9,650 .0011996 -.000357, .0027562 .1309 <.2142 2,764 -.0006113 -.0035482, .0023255 .6832 .8396 
Reasoning 
(comp) 
9,612 -.0010418 -.0027634, .0006798 .2356 .3227 2,763 -.0021697 -.0053804, .0010411 .2686 .8058 
Memory (comp)  9,964 .0009278 -.0004027, .0022584 .1717 .2576 2,848 .0007733 -.0016947, .0032413 .6198 .8393 
Global CF 
(comp) 
14,284 .0005975 -.0004228, .0016178 .2510 .3227 3,933 .0007286 -.0012778, .0027349 .4765 .8393 
 
Abbreviations: CF, cognitive function; CI, confidence interval; FDR, False Discovery Rate;  MET, Metabolic Equivalent of Task; PA , physical activity; Uncorr, uncorrected 
a: All expressed as z scores, except Prospective Memory which is expressed as an odds ratio 
b: Adjusted for: alcohol binge, alcohol frequency, antihypertensive medication, apoe-e4 allele count, BMI, cardiovascular disease dx, dementia genetic risk score, diabetes dx, distance to 
major road, friend and family visits, gender, hdl cholesterol, head injury dx, household income, kidney disease dx, KJ of energy, ldl cholesterol, living alone status, manual work, mood disorder 
dx, musculoskeletal dx, neurological disorder dx, neuroticism score psychosis dx, psychotropic medication, salt added to food, smoking status, Townsend deprivation score, trauma status, 
waist circumference, worrier status. Also adjusted for technical covariates used with genetic risk scores.  
c: Probability adjusted using the Simes-Benjamini-Hochberg method implemented in the Stata qqvalue package. 
d: Processing speed composite = mean of Digit Symbol Substitution and Reaction Time (assuming non-missing on both measures)  
e: Executive function composite = mean of Tower Rearranging, Trails A and Trails B completion time (assuming non-missing on two measures)  
f: Reasoning composite = mean of Reasoning test and Matrix Pattern Completion (assuming non-missing on both measures)  
g: Memory composite = mean of Pairs Matching, Numeric Memory and Paired Associate Learning (assuming non -missing on two measures)  
h: Global CF = mean of z scores on ten tests (assuming at least two non-missing values 
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Appendix 3: Original research proposal 
Final Approved MRP Proposal 
Title: Examining the relationship between physical activity and cognitive function using a 
large population cohort 
Student ID: 0902142 
Date of submission: 27.01.2020  
Version number: 011 
Word count (max): 3231 (3000) 
Abstract 
Background: Elucidating modifiable factors that may confer protection against cognitive 
decline is an important area of investigation. Physical activity represents one such factor and 
has generated substantial evidence regarding its protective benefit. However, in 
epidemiological research the presence of multiple covariates has posed challenges to 
obtaining unconfounded estimates of associations between exposure and outcome variables, 
which means that we do not know true magnitude of the relationship between physical 
activity and cognitive function. The present study aims to address this issue by using the very 
large cohort dataset, UK Biobank, to construct and test a comprehensive model of this 
relationship.  
Aims: To construct and test multivariate models in order to estimate the magnitude of the 
relationship between physical activity and cognitive function.  
Methods: (i) A systematic review of observational studies reporting on the association 
between physical activity and cognitive function/decline, producing a narrative synthesis and 
graphical causal model.  
(ii) Longitudinal analysis using the UK Biobank dataset to test the model constructed in the
review phase. 
Applications: Contributing to the understanding of complex relationships between 
demographic, clinical and lifestyle factors and cognitive health, which may have an impact 
on intervention and policy development.  
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Introduction 
Cognitive function and decline 
The term cognitive function (CF) describes a set of mental abilities that enable 
humans to acquire and use the knowledge and skills necessary to function in everyday life. A 
person’s CF can affect many areas of their life, such as their education, employment and 
socio-economic status, and this wide-ranging impact has been conceptualised as the 
‘cognitive footprint’ (Knapp, Kung, Rossor, & Stoner, 2018). Whilst some decline in CF is 
part of normal aging (Harada, Love, & Triebel, 2013), more pronounced decline can range 
from preclinical mild cognitive impairment (MCI) through to full neurodegenerative disease 
presentations such as Alzheimer’s disease and other dementias. Such presentations result in 
reduced quality of life and carry significant disease burden (Gauthier et al., 2006; Nichols et 
al., 2019). The biggest risk factor for cognitive decline (CD) is age (Hebert, Weuve, Scherr, 
& Evans, 2013), and, as people are living longer, the number of people living with dementia 
globally has more than doubled since 1990 (Nichols et al., 2019). Whilst age itself is a risk 
factor not amenable to modification, there is growing evidence that a range of lifestyle 
factors, such as physical activity, can offer protective benefit against CD and, importantly, 
represent feasible targets for intervention (Baumgart et al., 2015).  
Physical activity and cognitive health 
Physical activity (PA) is defined as “... any bodily movement produced by skeletal 
muscles that requires energy expenditure ” (Casperson, Powell and Christenson, 1985, p.1). 
A lack of PA is a leading risk factor for global mortality and is associated with health 
outcomes such as obesity, diabetes, cancer and heart disease (Lear et al., 2017). Researchers 
commonly conceptualise PA along a continuum, with levels ranging from ‘sedentary’ 
through to ‘light’, ‘moderate’, ‘vigorous’ and ‘high’ (Norton, Norton, & Sadgrove, 2010). 
Importantly, recent approaches identify sedentary behaviour (SB) as a construct which is 
related to PA but which can be independently associated with health outcomes (Katzmarzyk, 
2010). In recent research using UK Biobank data, (Celis-Morales et al., 2019) categorised 
people according to their values on these two constructs to create four groups: high PA/low 
SB, “busy bees”, (2) high PA/high SB; (3) low PA/low SB; and (4) low PA/SB time, “couch 
potato.”  
Besides these physical health outcomes, a growing literature also link PA to cognitive health 




which demonstrate reduced risk of CD in people with higher levels of PA (Blondell, 
Hammersley-Mather, & Veerman, 2014) . There are several pathways by which the benefits 
of PA appear to operate. At the cellular level PA appears to facilitate neurogenesis, 
synaptogenesis and angiogenesis (Lista & Sorrentino, 2010),  which may produce changes in 
grey matter volume (Erickson, Leckie, & Weinstein, 2014) and white matter integrity (Smith 
et al., 2016). Furthermore, the cardiovascular effects of PA appear to protect against 
antherosclerosis (González et al., 2018).  
This relationship between PA and CF is particularly relevant for people who are less 
physically active, such as those experiencing mental illness. Research shows that PA levels 
are low amongst patients with mood disorders and schizophrenia (Vancampfort et al., 2017), 
and even amongst those with more common conditions such as anxiety (Stubbs et al., 2017).  
Cohort studies  
 Whilst the body of evidence linking PA to CF is already substantial, it is also 
recognised that, in health and epidemiological research, the presence of covariates which are 
associated with both exposure and outcome variables makes measuring and controlling for 
confounding particularly challenging (McNamee, 2003). However, the recent availability of 
very large cohort datasets containing a wide breadth of variables, makes constructing causal 
structural models which include all of the necessary covariates, whilst retaining the statistical 
power necessary to detect even weak effects, increasingly feasible (McIntosh et al., 2016). 
The present study seeks to take advantage of such opportunities in order to rigorously 
examine the relationship between PA and CF, whilst taking account of covariate and 
confounder effects.  
Aims and hypotheses 
 The aim is to examine the relationship between PA and CF in the middle-aged-to 
early-old aged population of the UK Biobank cohort dataset. This will be conducted in two 
related phases. Phase one will consist of a systematic review of studies reporting the 
association between PA and CF, synthesising the relevant literature to produce an evidence-
based graphical model of this relationship, including the covariates that need to be included 
in multivariate statistical analyses. The second phase will be informed by the outcomes of the 
first and will take a longitudinal approach, testing multivariate causal models of the 
relationship of interest. At this stage it is anticipated that the review phase will yield two 
hypotheses to be tested in phase two:  
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(i) There is a significant positive association between PA at baseline and CF at follow-up, and 
this will be smaller in magnitude, but still statistically significant, when adjusted for 
confounders.  
(ii) This relationship is mediated by structural neural differences such as grey matter
volume and white matter integrity. 
Plan of investigation & Methods 
Phase one (systematic review):  
 The review phase will seek to answer the following questions: 
(i) In UK adults, what is the magnitude of relationship between PA and cognitive
function/impairment. 
(ii) What sociodemographic, clinical and other factors do studies also report as being
associated with cognitive function/impairment? 
Within the literature CF is commonly conceptualised using performance-based 
neuropsychological tests, neuroimaging measures such as structural Magnetic Resonance 
Imaging (MRI) and by clinical diagnoses of dementia. With feasibility in mind, the review 
will pertain only to studies which used neuropsychological tests to measure CF. The resulting 
articles will be subject to the conventional stages of screening against a set of inclusion 
criteria, followed by data extraction and critical appraisal.  
The novel component of this review will come at the synthesis stage, at which it is proposed 
to construct a causal diagram, known as a directed acyclic graph (DAG). DAGs visually 
encode structural causal models by drawing nodes to represent variables and single-headed 
arrows between nodes to represent the proposed direction of causation. The DAG resulting 
from the review will identify and depict the variables which must be measured and controlled 
for to obtain an unconfounded effect size estimate of the relationship between PA and CF. To 
construct the relevant DAG the review process will utilise a recently developed protocol: 
Evidence Synthesis for Constructing Directed Acyclic Graphs (ESC-DAG) (Ferguson et al., 
2019). There are three stages within the ESC-DAG protocol: 1) The findings of each included 
study are depicted in a DAG; 2) each DAG is evaluated using a set of causal inference 




integrated DAG. The final product thus constitutes a complex multivariate model of the 
relationship between exposure and outcome variables.  
Phase two (cohort study):  
 One a DAG has been constructed, this will be investigated empirically using the UK 
Biobank dataset.  
Participants: 
UK Biobank is a general population-based prospective study aiming to examine the 
genetic and environmental determinants of disease (Sudlow et al., 2015). The resource 
consists of data pertaining to 502,520 individuals who were aged 40-69 years at recruitment, 
(mean 56.5 years); all were registered with the NHS and living near one of 22 assessment 
centres.  
Recruitment:  
From 2006 to date, baseline and follow-up data have been collected at assessment 
visits lasting two hours.  
Inclusion and exclusion criteria:  
The subset of the overall cohort which will be used to answer each research question 
will be determined by the systematic review phase. This will elucidate the variables which 
will be necessary to include within the model, and thus only participants who have 
overlapping completion on the relevant measures will be included. 
Measures:  
 The exposure variable is PA, of which there are several measures in the Biobank 
dataset. Previous Biobank studies have used the self-report measure the International Physical 
Activity Questionnaire (IPAQ) (Celis-Morales et al., 2019) whilst others have opted to use 
the objective measure of accelerometry data (Doherty et al., 2017). The most appropriate 
variables to use as primary measures in analysis will be elucidated early in the review process 
and will be added to the analysis protocol as soon as they are selected. The outcome variable 
is CF which was assessed in UK Biobank using a short, bespoke computerised battery of tests 
measuring memory, reasoning and reaction time. These battery of tests show moderate to 
good convergent validity with well-established cognitive tests and moderate to high short-
term test-retest reliability (Fawns-Ritchie & Deary, 2019). Structural neural features such as  
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grey matter volume and white matter integrity have also been measured in Biobank (Miller et 
al., 2016) and will be treated as mediators in the present study. The covariates which are 
included in the model will be elucidated by the review process 
Design: 
This is a large population prospective cohort study utilising longitudinal analysis to 
examine the relationship between exposure and outcome variables, as well as mediating 
causal pathways. Of the 502,520 at baseline, around 100,000 have been followed up at least 
once, making longitudinal analysis possible (Conroy et al., 2019).  
Research procedures: 
Conducting the project will entail extracting the relevant variables from the UK 
Biobank database, cleaning/preprocessing the dataset and using the software programme 
Stata to perform analysis. Training will be provided by the project supervisor and regular 
collaboration with a local group of Biobank researchers will be utilised.  
Data analysis 
Stata will be used to conduct descriptive statistics and multiple regression models. 
Mediation analysis will also be conducted in Stata, to examine potential causal pathways such 
as structural brain differences. Alternative versions of the analyses will be conducted on a 
planned basis to check the sensitivity of the results to different specifications, for example 
using self-report vs accelerometry data to represent PA. The variables to be treated as 
primary and secondary will be reported in an analysis protocol prior to conducting analysis. 
Given the multiplicity of analyses and the very large sample size (making low p-values more 
likely), the threshold for statistical significance will be set at p < 0.01, and false discovery 
rate corrections will be applied if multiple models are used to test the same hypothesis. This 
threshold has been used in previous Biobank studies of a similar scope (Cullen et al., 2015). 
Given that mental health status is anticipated to be an important covariate, planned analysis 
of interaction effects according to mental health status will also be added to the analysis 
protocol once the most relevant measures have been elucidated.  
Justification of sample size: 
Feasibly testing such a complex model is made possible by the size of the dataset available 





the baseline cohort is very large, there are relatively fewer participants with data on 
some measures (around 40,000 for neuroimaging) and the sample size with complete data on 
all covariates will be smaller again. Nevertheless, assuming that the smallest sample size for 
analysis in this study is as low as 20,000 (the neuroimaging sample, with a conservative 
estimate of 50% having complete data), this would still be ample to reliably estimate 
regression and mediation models to detect small effect sizes (Fritz & MacKinnon, 2007).  
Settings:  
As no data collection is required the setting of this research is non-clinical and will 
take place largely on the University of Glasgow campus.  
Equipment:  
The only equipment required is a licence for the statistical software Stata; the 
University has a site licence for this.  
Health and safety issues:  
None  
Ethical issues:  
All data to be used are pre-existing, and have been anonymised by UK Biobank 
centrally using a coding system to which researchers do not have access. UK Biobank has 
approval from the NHS National Research Ethics Service as a research tissue bank and 
separate project-specific ethical approval is not required by approved researchers using data 
released by UK Biobank. In accordance with the research supervisor’s contract with UK 
Biobank, the data will be stored and analysed on a password-protected University network 
drive. The primary researcher will be registered as an approved researcher with Biobank 
before accessing data. All UK Biobank participants gave informed consent and those who 
withdraw are removed from the dataset on a regular basis. The findings of the current project 
will aim to be published in peer reviewed journals. 
Ethical issues relevant to largescale cohort studies, and in particular Biobank, will be 
considered and discussed in the main write-up of the thesis.  




The findings will be relevant in the context of the UK’s aging population, as strategies 
and policies to prevent CD are developed. This research may also be relevant to those 
designing interventions for other clinical subgroups at risk of CD such as people with major 
mental illness.  
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(i) Anonymised health and safety form  
 
APPENDIX 8.5 HEALTH & SAFETY FORM 
HEALTH AND SAFETY FOR RESEARCHERS 
 
1. Title of Project: Examining the relationship between physical activity and cognitive 
function using a large population cohort 
2. Trainee: 0902142 
3. University Supervisor: __________ 
4. Other Supervisor(s):  
5. Local Lead Clinician: N/A 
6. Participants: (age, group or subgroup, pre- or post-treatment, etc): Pre-existing 
cross sectional and longitudinal UK Biobank data. Participants were 502,520 UK adults 
aged 40-69. Around 100,000 attended follow-up assessment and their data will be used in the 
present study. No new data collection required for the present study.  
7. Procedures to be applied (eg, questionnaire, interview, etc): No new data 
collection required. Participants were assessed on a variety of clinical, social and other 
measures in assessment sessions lasting two hours. Some participants have attended 
follow up sessions where more measures were administered, including brain scans.  
8. Setting (where will procedures be carried out?): No data collection procedures. 
Analysis to be carried out on university campus.  
i) General: 
ii) Are home visits involved Y/N: No 
8. Potential Risk Factors Identified (see chart): No  
9. Potential Risk Factors Considered (for researcher + participant safety):  











(i) Anonymised research costs and equipment form  
APPENDIX 8.6 RESEARCH COSTS & EQUIPMENT 
RESEARCH EQUIPMENT, CONSUMABLES AND EXPENSES 
Trainee: 0902142 
Year of Course: 2020 
Intake Year: 2018 
Please refer to latest stationary costs list (available from student support team):  
Item Details and amount 
required 
Cost or specify if to 
request to borrow from 
department  
Stationary  N/A Subtotal:  
Postage  N/A Subtotal:  
Photocopying and laser 
printing 
N/A Subtotal:  
Equipment and software Laptop (Dell16) borrowed 
from department to access 
STATA software  
Subtotal: 0 (borrowed from 
department)  
Measures  N/A Subtotal:  
Miscellaneous  N/A Subtotal:  
Total  0 0 
 
 
For any request over £200 please provide further justification for all items that 
contribute to a high total cost estimate. Please also provide justification if 
costing for an honorarium: 
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(i) Plain Language Summary:
Plain English summary 
ID: 0902142 
Date of submission: 27.01.2020 
Title: Examining the relationship between physical activity and cognitive 
function using a large population cohort 
Wordcount: 500 
Background:  
Cognitive function (CF) describes the range of mental abilities such as memory, 
language, problem solving and visual ability that make it possible for humans to 
learn and use knowledge and skills. When CF is reduced (cognitive decline) 
people can find it hard to participate fully in their daily activities and their 
quality of life may suffer. Cognitive abilities tend to get worse with age and, as 
the UK has an aging population, understanding how to protect against this is an 
important topic for research. People who do more physical activity (PA; e.g. 
exercise, house work) have been found to have a lower chance of cognitive 
decline. This might be because PA helps keep the brain healthy. However, there 
are lots of other factors that are related both to PA and CF and so the true 
strength of the relationship between the two remains unclear. UK Biobank is a 
very large study of UK adults who were assessed using measures of many 
clinical, social and other background factors. Some of them also had brain 
scans. This wide range of data allows us to examine the relationship between 
PA and CF in a detailed way.  
Aims: 
By reviewing previous research, we will identify the background factors that 







(i) between PA and CF. We will then draw a diagram showing the 
relationships between these factors.  
(ii) We will use statistical models to see how strong the relationship 
between PA and CF is, after taking account of the other 
important factors in the diagram. We will also test whether this 
relationship is explained by measures of brain health.  
Methods 
Participants: Participants were 502,520 UK adults aged 40-69. Around 100,000 
attended follow-up assessment and their data will be used in the present study.  
Recruitment: Participants were invited to attend assessment centres around the 
UK. No further recruitment is needed for the present study.  
Consent: All UK Biobank participants gave informed consent and those who 
withdraw are removed from the dataset on a regular basis 
Design of study: The study will look at whether people who reported more 
physical activity at their first assessment have higher cognitive function at their 
follow-up assessment, and whether there were differences in their brain scans.   
Data collection: All participants attended a two-hour baseline assessment. 
Some also attended follow-up assessments, including brain scans. No new data 
collection is needed for the present study.  
Key ethical issues: All data to be used are pre-existing and has been 
anonymised by UK Biobank centrally using a coding system to which 
researchers do not have access. UK Biobank has approval from the National 
Health Service (NHS) National Research Ethics Service and separate project-
specific ethical approval is not required for the present study.  
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Practical applications and dissemination: The findings of the study may be 
useful in designing interventions and policy regarding physical activity and 
cognitive health and will be aimed to be published in peer reviewed journals. 
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